Science Applications International Corp — Proxy Solicitation & Information Statement 2025

Apr 23, 2025

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐ Preliminary Proxy Statement

☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☒ Definitive Proxy Statement

☐ Definitive Additional Materials

☐ Soliciting Material Pursuant to § 240.14a-12

Science Applications International Corporation

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

☒ No fee required

☐ Fee paid previously with preliminary materials

☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

SAIC ® a premier Fortune 500 ® mission integrator focused on advancing the

power of technology and innovation to serve and protect our world.

Our robust portfolio of offerings across the defense, space, civilian and

intelligence markets includes secure high-end solutions in mission IT,

enterprise IT, engineering services and professional services. We integrate

emerging technology, rapidly and securely, into mission critical operations

that modernize and enable critical national imperatives.

We are approximately 24,000 strong; driven by mission, united by purpose,

and inspired by opportunities. Headquartered in Reston, Virginia, SAIC

has annual revenues of approximately $7.5 billion. For more information,

visit saic.com. For ongoing news, please visit our newsroom.

PURPOSE

Advance the power of

technology and

innovation to serve and

protect our world

VISION

We will be our nation’s

most trusted solutions

integrator to secure and

digitally evolve U.S.

critical missions with our

customers

MISSION

Partner with our

customers to transform

government, by creating

and integrating digital

solutions that address

national imperatives with

our diverse talent and

innovative tech

Integrity

Demand unwavering

honesty, ethics and

authenticity in yourself

and others

Innovation

Empower our people to

take appropriate risks

and leverage emerging

technology to solve our

customers’ most complex

problems

Inclusion

Respect and value

our people and

passionately partner

with our customers

and our communities

VALUES

Fiscal year 2025 saw the implementation of a new, multi-year growth

strategy for SAIC. The company rapidly pivoted its portfolio, go-to-market,

brand and culture toward integrating a broader set of emerging

technologies into complex mission environments across U.S. defense,

space, civilian and intelligence markets. The period was marked by

investments in SAIC’s innovation ecosystem, to include increasing ventures

in autonomous and AI technologies, expanding our native cloud, data and

cyber capabilities and partnering strategically with commercial providers

from start-ups to hyper-scalers. This enabled us to deploy faster and more

secure solutions to advance SAIC’s customer missions and grow the

company organically, profitably and strategically.

Along with SAIC’s Board of Directors, the Executive Leadership Team and I

are grateful for your support as we drove mission integration outcomes for

our customers amidst the challenges of a dynamic operating environment.

Fiscal 2025 results reflect our ability to deliver in the near term while laying

the groundwork for future success.

With a shifting industry landscape, our mission aligns with the government’s

focus: expanding commercial technologies into the national security

ecosystem with speed and precision and leveraging technology for

efficiencies and improved citizen experiences in civilian markets. We

remain mission-focused, balanced and steadfast in partnership with our

customers, our employees, and you, our shareholders.

I’m happy to share that fiscal 2025 delivered strong financial results.

Revenues increased $35 million to $7.48B, reflecting organic growth of

3.1% and increased adjusted diluted EPS of $9.13 by 16% as compared to

fiscal year 2024. We returned $602M of capital to shareholders via $527M

of share repurchases and $75M of dividends.

Our book of business remains solid, and our underlying business is

improving due to our portfolio’s alignment with critical customer missions

and the vital importance of our role as a mission integrator - serving as a

bridge that efficiently connects existing governmental infrastructure with

differentiated technology to rapidly respond to our customer’s needs.

Along with SAIC’s

Board of Directors, the

Executive Leadership Team

and I are grateful for your

support as we drove

mission integration outcomes

for our customers amidst

the challenges of a dynamic

operating environment.

Fiscal 2025 results reflect

our ability to deliver in the

near term while laying

the groundwork for

future success."

Letter to Our Shareholders

Toni Townes-Whitley

SAIC Chief Executive Officer

Letter to Our Shareholders

At SAIC, we hold dear our company’s core values – integrity, innovation

and inclusion -- through respect and value for our people. As we begin

fiscal year 2026, we are refining our portfolio and go-to-market activities,

leveraging our commercial operating segment and innovation factory to

expedite commercial tech solutions. We expect changes to the

procurement environment that will place a greater emphasis on the infusion

of technology to modernize our customers’ environment and further

advance their missions. We see this rapid acceleration of modernization in

direct alignment with our strategy, investments and demonstrated program

execution.

We also remain disciplined in our investments and capital deployment,

focusing on technology-enabled solutions and capabilities, secure multi-

cloud, digital engineering, operational artificial intelligence and secure data

analytics and other mission-critical technologies desired by our customers.

I am proud of our fiscal year 2025 performance and am inspired by the

passion and the commitment of our 24,000 employees who partner with our

customers, efficiently and empathetically, transforming government on a

daily basis.

On behalf of the Board of Directors, the leadership team and SAIC’s

dedicated employees, I thank you for your continued confidence in SAIC.

Sincerely,

Toni Townes-Whitley

SAIC Chief Executive Officer

NOTICE OF VIRTUAL ANNUAL MEETING

OF STOCKHOLDERS

The annual meeting of stockholders of

Science Applications International

Corporation ("SAIC"), a Delaware

corporation, will be held on Wednesday,

June 4, 2025, at 9:00 a.m. (PT) as a

virtual meeting at

www.virtualshareholdermeeting.com/

SAIC2025. We believe that a virtual

annual meeting of stockholders provides

greater access to those who may want to

attend and, therefore, have chosen this

over an in-person meeting. In addition,

our Proxy Statement and our Annual

Report on Form 10-K for our fiscal year

ended January 31, 2025, are available at

www.proxyvote.com. Information on

these websites, other than these

materials, is not a part of the proxy

solicitation materials.

The foregoing items of business are fully

described in our Proxy Statement made

available on the Internet and, upon

request, in paper copy. Our Board of

Directors has set the close of business

on April 7, 2025 as the record date for

the determination of stockholders who

are entitled to notice of and to vote at the

annual meeting and at any and all

adjournments, postponements or

continuations thereof. A list of

stockholders entitled to vote at the

meeting will be available for inspection

for at least 10 days prior to the meeting.

If you are a stockholder and want to

inspect the stockholder list, please send

a written request to our Corporate

Secretary at Legal-

Department@saic.com to arrange for

electronic access to the stockholder list.

12010 Sunset Hills Road

Reston, Virginia 20190

Meeting information	Ways to vote
Date and time June 4, 2025 9:00 a.m. (PT)	Internet	Virtual Annual Meeting
Location www.virtualshareholdermeeting.com/ SAIC2025	Telephone
Record date April 7, 2025	Mail
Your vote is important For specific instructions regarding how to vote, please refer to the questions and answers beginning on page 6 of this Proxy Statement or the instructions on the proxy and voting instruction card. Submitting a proxy or voting instructions will not prevent you from attending the virtual annual meeting and voting at the meeting if you so desire but will help us secure a quorum and reduce the expense of additional proxy solicitation.

Items of business
1	To elect eleven directors
2	To conduct a non-binding, advisory vote to approve the compensation of our named executive officers ("Say-on-Pay")
3	To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 30, 2026
4	To transact such other business as may properly come before the meeting or any adjournments, postponements or continuations of the meeting

By Order of the Board of Directors

Hilary L. Hageman | Corporate Secretary | Reston, Virginia | April 23, 2025

saic.com | 1

SUMMARY INFORMATION

This summary highlights information contained elsewhere in this Proxy Statement. It does not contain all the information that you

should consider, and you should carefully read the entire Proxy Statement as well as our Annual Report on Form 10-K for our

fiscal year ended January 31, 2025, before voting.

Annual Meeting of Stockholders

• Time and Date:	9:00 a.m. (PT) on June 4, 2025
• Website:	www.virtualshareholdermeeting.com/SAIC2025
• Record Date:	April 7, 2025
• Voting:	Stockholders as of the record date are entitled to vote.
• Attendance:	All stockholders and their duly appointed proxies may attend the virtual meeting.

Meeting Agenda and Voting Recommendations

Agenda Item	Board Recommendation	Page
Proposal 1: Election of eleven directors.	FOR each nominee	10
Proposal 2: Approval of a non-binding, advisory vote to approve the compensation of our named executive officers ("Say-on-Pay").	FOR	37
Proposal 3: Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 30, 2026.	FOR	71

Board Nominees

The following table provides summary information about each director nominee. Each director nominee is elected annually by a

majority of votes cast by our stockholders.

	Age	Director Since	Principal Occupation	Committees
Garth N. Graham	50	2021	Director and Global Head of Healthcare for YouTube, LLC	• Compensation • Technology
Carolyn B. Handlon	67	2022	Former Financial Executive and Treasurer for Marriott International, Inc.	• Audit • Nominating
Yvette M. Kanouff	59	2019	Partner for JC2 Ventures	• Audit • Technology (Chair)
Timothy J. Mayopoulos	66	2015	Former President of Blend Labs, Inc.; former President & Chief Executive Officer of the Federal National Mortgage Association (Fannie Mae)	• Audit • Compensation • Nominating
Katharina G. McFarland	65	2019	Private Consultant and former Assistant Secretary of Defense (Acquisition), Dept. of the Army	• Nominating (Chair) • Technology
Milford W. McGuirt	68	2021	Former Managing Partner at KPMG, LLP	• Audit (Chair) • Nominating
Donna S. Morea	70	2013	Chair of SAIC's Board; former President of U.S., Europe, and Asia for CGI Group	• Compensation • Nominating
James C. Reagan	66	2023	Former Chief Financial Officer at Leidos Holdings, Inc.	• Audit • Compensation
Steven R. Shane	67	2013	Former partner at Accenture PLC	• Compensation (Chair) • Technology
John K. Tien, Jr. (1)	61	2024	Former Deputy Secretary of the U.S. Department of Homeland Security	• Nominating
Toni Townes- Whitley	61	2023	Chief Executive Officer of SAIC	• Technology

(1) Mr. Tien was appointed to the Board of Directors effective as of December 2, 2024.

2 | Science Applications International Corporation | 2025 Proxy Statement

SUMMARY INFORMATION

Corporate Governance Highlights

●
Director Elections ✓ Annual Board of Directors Elections ✓ Directors Elected by a Majority of Votes Cast
Board of Directors Meetings in Fiscal 2025 ✓ Four Full Board of Directors Meetings ✓ Seven Independent Director-Only Sessions
Evaluating and Improving Board of Directors Performance ✓ Annual Board of Directors Self-Evaluation Required ✓ Annual Review of Independence of Board of Directors ✓ Committee Self-Evaluations Required ✓ Board of Directors Orientation/Education Programs
Aligning Director and Stockholder Interests ✓ Director and Executive Stock Ownership Guidelines ✓ Annual Equity Grant to Non-Employee Directors
Published Governance Policies and Practices (available at investors.saic.com) ✓ Corporate Governance Guidelines ✓ Code of Conduct ✓ Charters for Committees of Board of Directors ✓ Position Description of Chair of Board of Directors

saic.com | 3

TABLE OF CONTENTS

	Information About the Annual Meeting of Stockholders	5
Proposal 1	Proposal 1 - Election of Directors	10
	Majority Voting Standard in Uncontested Director Elections	12
	Recommendation of the Board of Directors	12
	Nominees for Election to the Board of Directors	13
Corporate Governance	Corporate Governance	20
	Corporate Governance Guidelines	21
	Proxy Access	21
	Code of Conduct	21
	Director Independence	21
	Criteria for Board Membership	22
	Board Leadership Structure	23
	The Board’s Role in Risk Oversight	24
	Corporate Responsibility	25
	Board of Directors Meetings and Committees	26
	Board of Directors Compensation	32
	Related Party Transactions	35
	Communication with the Board of Directors	36
Proposal 2	Proposal 2 - Advisory (Non-Binding) Vote on Executive Compensation	37
	Vote Required	38
	Recommendation of the Board	39
Compensation Discussion and Analysis
	Compensation Discussion and Analysis	40
	Human Resources and Compensation Committee Report	55

4 | Science Applications International Corporation | 2025 Proxy Statement

TABLE OF CONTENTS

Executive Compensation	Executive Compensation	56
	Summary Compensation Table	57
	Grants of Plan-Based Awards	58
	Outstanding Equity Awards at Fiscal Year-End	59
	Options Exercised and Stock Vested	60
	Nonqualified Deferred Compensation	60
	Potential Payments upon Termination or a Change in Control	61
	CEO Pay Ratio	66
	Pay Versus Performance	66
Proposal 3	Proposal 3 - Ratification of Appointment of Independent Registered Public Accounting Firm	71
	Vote Required	72
	Recommendation of the Board	72
Audit Matters	Audit Matters	73
	Audit Committee Report	74
	Independent Registered Public Accounting Firm	74
	Audit and Non-Audit Fees	75
Other Information	Other Information	76
	Stock Ownership of Certain Beneficial Owners	77
	Stock Ownership of Directors and Officers	78
	Delinquent Section 16(a) Reports	78
	Stockholder Proposals and Director Nominations for the 2025 Annual Meeting	79
	Annual Report on Form 10-K	79
	Appendices	80
	Appendix A: Non-GAAP Financial Measures	81

saic.com | 5

INFORMATION ABOUT THE ANNUAL MEETING OF STOCKHOLDERS

6 | Science Applications International Corporation | 2025 Proxy Statement

INFORMATION ABOUT THE ANNUAL MEETING OF STOCKHOLDERS

FOUR DIFFERENT WAYS TO VOTE YOUR SHARES
●	By Internet You may submit a proxy or voting instructions over the Internet by going to www.proxyvote.com or by scanning the QR code on your proxy and voting instruction card with a smart phone and following the instructions.
●	By Mail If you received your proxy materials in the mail, you may complete, sign and return the accompanying proxy and voting instruction card in the postage-paid envelope provided.

INFORMATION ABOUT THE

ANNUAL MEETING OF STOCKHOLDERS

●

By Telephone You may submit a proxy or voting instructions by calling 1-800-690-6903 and following the instructions.

●

At The Virtual Annual Meeting If you are a stockholder of record you may electronically attend the virtual annual meeting and vote your shares at www.virtualshareholdermeeting.com/SAIC2025 during the meeting. You will need to provide your 16-digit control number that is on your Notice of Internet Availability of Proxy Materials or your proxy card if you receive a printed copy of the proxy materials by mail.

Proxy Statement

This Proxy Statement is being furnished to the stockholders of Science Applications International Corporation ("SAIC"), a

Delaware corporation, in connection with the solicitation of proxies by our Board of Directors ("Board") for use at our annual

meeting of stockholders to be held on Wednesday, June 4, 2025, at 9:00 a.m. (PT) as a virtual meeting via webcast at

www.virtualshareholdermeeting.com/SAIC2025, and at any and all adjournments, postponements or continuations thereof. This

Proxy Statement and the proxy and voting instruction card are first being sent or made available to our stockholders on or about

April 23, 2025.

Information About Voting Rights and Solicitation of Proxies

Who is entitled to vote at the annual meeting?

Only stockholders of record of our common stock as of

the close of business on our record date of April 7, 2025,

are entitled to notice of, and to vote at, the annual

meeting. As of April 7, 2025, there were 47,167, 287

shares of common stock outstanding. We have no other

class of capital stock outstanding.

Who may attend the annual meeting?

All stockholders as of our record date of April 7, 2025, or

their duly appointed proxies, may attend the virtual

annual meeting as well as vote and submit questions

during the webcast of the meeting by visiting

www.virtualshareholdermeeting.com/SAIC2025 and

entering the 16-digit control number included in our

Notice of Internet Availability of Proxy Materials or on

your Proxy card (if you received a printed copy of the

proxy materials).

Why hold a virtual annual meeting?

We believe that a virtual stockholder meeting provides

greater access to those who may want to attend our

annual meeting and, therefore, have chosen this over an

in-person meeting. We ensure that at our virtual annual

meeting, all attendees are afforded the same rights and

opportunities to participate as they would at an in-person

meeting. These procedures include the ability for

stockholders to ask questions during the course of the

meeting, post appropriate questions received during the

meeting for review by other participants, review our

corresponding answers to such questions on our

Investor Relations website at investors.saic.com as soon

as possible after the meeting and access technical

support staff during the meeting in the event of

difficulties arising from the use of the virtual meeting

platform. We continue to receive positive feedback from

our stockholders as we adopt best practices and new

technologies for our annual meeting, Proxy Statement

and related materials. We evaluate annually the method

saic.com | 7

INFORMATION ABOUT THE ANNUAL MEETING OF STOCKHOLDERS

of holding the annual meeting, taking into consideration

the above factors as well as business and market

conditions and the proposed agenda items. We continue

to believe that holding our annual meeting virtually over

the internet is the right approach for our company, as it

enables more of our geographically diverse base of

stockholders to participate in our annual meeting.

What constitutes a quorum?

The presence, either in person or by proxy, of the

holders of a majority of the total voting power of the

shares of common stock outstanding as of April 7, 2025,

is necessary to constitute a quorum and to conduct

business at the annual meeting. Abstentions and broker

“non-votes” will be counted as present for purposes of

determining the presence of a quorum.

What is a broker “non-vote”?

A broker “non-vote” occurs when a broker, bank or other

nominee holding shares for a beneficial owner does not

vote on a particular proposal because the nominee does

not have discretionary voting power with respect to that

matter and has not received voting instructions from the

beneficial owner. In tabulating the voting results for a

particular proposal, broker “non-votes” are not

considered entitled to vote on that proposal. Broker

“non-votes” will not have an effect on the outcome of any

matter being voted on at the meeting, assuming a

quorum is present.

Unless you provide voting instructions to any broker

holding shares on your behalf, your broker may not use

discretionary authority to vote your shares on any of the

matters to be considered at the annual meeting other

than the ratification of our independent registered public

accounting firm. Please vote your shares or provide

voting instructions to your broker so your vote can be

counted.

How many votes am I entitled to?

Each holder of common stock will be entitled to one vote

per share, in person or by proxy, for each share of

common stock held in the stockholder’s name as of

April 7, 2025, on any matter submitted to a vote of

stockholders at the annual meeting.

How do I vote my shares?

Shares of common stock represented by a properly

executed and timely proxy will, unless it has previously

been revoked, be voted in accordance with its

instructions. In the absence of specific instructions, the

shares represented by a properly executed and timely

proxy will be voted in accordance with the Board’s

recommendations as follows:

• FOR all of the company’s nominees to the Board;

• FOR the approval, on a non-binding, advisory basis, of

the compensation of our named executive officers

("Say-on-Pay"); and

• FOR the ratification of the appointment of Ernst & Young

LLP as our independent registered public accounting

firm for our fiscal year ending January 30, 2026.

No other business is expected to come before the

annual meeting; however, should any other matter

properly come before the annual meeting, the proxy

holders intend to vote such shares in accordance with

their best judgment on any additional matter.

You may revoke a previously delivered proxy by

delivering written notice of revocation to Hilary L.

Hageman, our Corporate Secretary, or by executing a

later dated proxy and giving written notice of the

revocation to our Corporate Secretary at any time before

the proxy is voted at the annual meeting. If you

submitted your proxy by Internet or by telephone, you

can vote again by voting over the Internet or by

telephone. We will honor the latest vote received. Proxy

holders will vote shares represented by written proxies, if

properly signed and returned to our Corporate Secretary,

in accordance with instructions of the stockholders.

What are the voting deadlines?

For shares not held in the Science Applications

International Corporation Retirement Plan (the “SAIC

Retirement Plan”), the deadline for submitting a proxy

using the internet or the telephone is 11:59 p.m. (ET) on

June 3, 2025. For shares held in the SAIC Retirement

Plan, the deadline for submitting voting instructions

using any of the allowed methods is 11:59 p.m. (ET) on

June 1, 2025.

How are the shares held by the SAIC Retirement

Plan voted?

Each participant in the SAIC Retirement Plan has the

right to instruct Vanguard Fiduciary Trust Company

("Vanguard"), as trustee of the SAIC Retirement Plan

(the “SAIC Trustee”), on a confidential basis, how to vote

his or her proportionate interests in all shares of

common stock held in the SAIC Retirement Plan. The

SAIC Trustee will vote all shares held in the SAIC

Retirement Plan for which no voting instructions are

received in the same proportion as the shares for which

voting instructions have been received by participants in

the SAIC Retirement Plan. The SAIC Trustee’s duties

with respect to voting the shares of common stock in the

SAIC Retirement Plan are governed by the fiduciary

provisions of the Employee Retirement Income Security

Act of 1974, as amended (“ERISA”). The fiduciary

provisions of ERISA may require in certain limited

8 | Science Applications International Corporation | 2025 Proxy Statement

INFORMATION ABOUT THE ANNUAL MEETING OF STOCKHOLDERS

circumstances that the SAIC Trustee override the votes

of participants with respect to the shares of common

stock held by the SAIC Trustee.

How are the shares held by the SAIC Stock Plans

voted?

Under the terms of our Management Stock

Compensation Plan and Key Executive Stock Deferral

Plan (collectively, the "SAIC Stock Plans"), Newport

Trust Company ("NTC"), as trustee of the SAIC Stock

Plans, has the power to vote the shares of common stock

held in the SAIC Stock Plans. NTC will vote all those

shares in the same proportion that our other stockholders

collectively vote their shares of common stock. If you are

a participant in any of the SAIC Stock Plans, you do not

have the right to instruct NTC how to vote or to otherwise

vote your proportionate interests in the shares of

common stock held in such SAIC Stock Plan.

What is the difference between a “stockholder of

record” and a “beneficial” holder?

These terms describe how the ownership of your shares

is reflected on the books of our transfer agent,

Computershare. If your shares are registered directly

with Computershare as a transfer agent, then you are a

“stockholder of record” of these shares. If your shares

are held in an account at a broker, bank, trust or other

similar organization, then you are a “beneficial” holder of

these shares. The organization holding your account is

considered the stockholder of record for purposes of

voting at the annual meeting. As a beneficial owner, you

have the right to instruct the organization on how to vote

the shares held in your account. If you wish to vote in

person at the virtual annual meeting, you must obtain a

valid proxy from the organization holding the shares.

Who is soliciting these proxies?

We are soliciting these proxies and the cost of the

solicitation will be borne by us, including the charges and

expenses of persons holding shares in their name as

nominee incurred in connection with forwarding Proxy

Materials to the beneficial owners of those shares. We

have retained Morrow Sodali LLC to assist in the

solicitation of proxies for the annual meeting for a fee of

approximately $10,000 plus reimbursement of out-of-

pocket expenses. In addition to the distribution of the

Proxy Materials by mail and through the Notice of

Internet Availability of Proxy Materials described below

under the caption "Internet Availability of Proxy

Materials," proxies may be solicited by our officers,

directors and employees in person, by telephone or by

email. These individuals will not be additionally

compensated for such solicitation but may be

reimbursed for reasonable out-of-pocket expenses

incurred in connection with such solicitation.

What is “householding” and how does it affect me?

We have adopted a procedure approved by the

Securities and Exchange Commission (“SEC”) called

“householding.” Under this procedure, we send only one

Proxy Statement and one annual report to eligible

stockholders who share a single address, unless we

have received instructions to the contrary from any

stockholder at that address. This practice is designed to

reduce our printing and postage costs. Stockholders who

do not participate in householding will continue to

receive separate proxy and voting instruction cards. We

do not use householding for any other stockholder

mailings.

If you are a registered stockholder residing at an

address with other registered stockholders and wish to

receive a separate copy of the Proxy Statement or

annual report, or if you do not wish to participate in

householding and prefer to receive separate copies of

these documents in the future, please contact our

mailing agent, Broadridge, either by calling toll-free

at (866) 540-7095, or by writing to Broadridge,

Householding Department, 51 Mercedes Way,

Edgewood, New York 11717. If you own shares through

a bank, broker or other nominee, you should contact the

nominee concerning householding procedures. We will

promptly deliver a separate copy of the Proxy Statement

or annual report to you upon request.

If you are eligible for householding, but you and other

stockholders of record with whom you share an address

currently receive multiple copies of the Proxy Statement

or annual report and you wish to receive a single copy of

each of these documents for your household, please

contact our mailing agent, Broadridge, at the telephone

number or address indicated above to bring this to our

mailing agent’s attention.

Where can I find the voting results of the annual

meeting?

We intend to announce preliminary voting results at the

annual meeting and publish final results in a Current

Report on Form 8-K to be filed with the SEC within four

business days of the annual meeting.

saic.com | 9

INFORMATION ABOUT THE ANNUAL MEETING OF STOCKHOLDERS

Internet Availability of Proxy Materials

As permitted by the rules and regulations of the SEC, we are using the Internet as a means of furnishing proxy materials to our

stockholders. We believe this method makes the proxy distribution process more efficient, lowers costs and helps in conserving

natural resources.

On or about April 23, 2025, we mailed to our stockholders a Notice of Internet Availability of Proxy Materials containing

instructions on how to access our proxy materials, including the proxy statement and annual report. The Notice of Internet

Availability of Proxy Materials also instructs you on how to access your proxy and voting instruction card to be able to vote

through the Internet or by telephone. Other stockholders, in accordance with their prior requests, and employees with regular

access to email through their company email address have received email notification of how to access our proxy materials

and vote via the Internet or by telephone or have been mailed paper copies of our proxy materials and a proxy and voting

instruction card.

The Proxy Statement and Annual Report are available at www.proxyvote.com.

10 | Science Applications International Corporation | 2025 Proxy Statement

saic.com | 11

PROPOSAL 1 - ELECTION OF DIRECTORS

PROPOSAL 1 -

ELECTION OF DIRECTORS

The Board unanimously

recommends a vote FOR

each nominee.

At the annual meeting, eleven directors are to be elected to serve for one-year terms and to hold such position until each

director’s successor is elected and qualified unless any of the directors resign or are removed prior to the end of their respective

term. All nominees have been nominated by the Board based on the recommendation of the Nominating and Corporate

Governance Committee thereof. To the best knowledge of the Board, all of the nominees are able and willing to serve. Each

nominee has consented to be named in this Proxy Statement and to serve if elected. Each nominee listed below is currently a

director of the company and, other than Mr. Tien, each was elected by the stockholders at our 2024 annual meeting of

stockholders. Mr. Tien was elected to serve as a director by the Board effective as of December 2, 2024, and is standing for

election by our stockholders as a director of the company for the first time at this year’s annual meeting. Mr. Tien was first

identified as a potential director candidate by one of our current non-executive directors. The candidate went through the

company's rigorous vetting process, including full background checks, and was selected based on his excellent credentials and

financial acumen. Mr. Tien was then evaluated by the Nominating and Corporate Governance Committee in advance of its

recommendation of his service as a director.

12 | Science Applications International Corporation | 2025 Proxy Statement

PROPOSAL 1 - ELECTION OF DIRECTORS

Majority Voting Standard in Uncontested Director Elections

We have adopted majority voting procedures for the election of directors in uncontested elections. In an uncontested election,

nominees must receive more “for” than “against” votes to be elected without further action. Abstentions and broker non-votes are

not counted as votes cast. As provided in our bylaws, a “contested election” is one in which the number of nominees exceeds the

number of directors to be elected. The election of directors at the 2025 annual meeting of stockholders is an uncontested election.

If an incumbent director receives more “against” than “for” votes, he or she is expected to tender his or her resignation in

accordance with our Corporate Governance Guidelines. The Nominating and Corporate Governance Committee will consider the

offer of resignation and recommend to the Board the action to be taken. The Board will promptly disclose its decision as to

whether to accept or reject the tendered resignation in a press release, Current Report on Form 8-K or other public

announcement.

Shares of common stock represented by properly executed, timely received and unrevoked proxies will be voted as instructed in

the proxy. In the absence of specific instructions, the shares represented by properly executed, timely received and unrevoked

proxies will be voted “for” each nominee. If any of the nominees listed below becomes unable to stand for election at the annual

meeting, the proxy holders intend to vote for any person designated by the Board to replace the nominee unable to serve.

Recommendation of the Board of Directors

The Board unanimously recommends a vote FOR each nominee.

saic.com | 13

PROPOSAL 1 - ELECTION OF DIRECTORS

Nominees for Election to the Board of Directors

Set forth below is a brief biography of each nominee for election as a director and a brief discussion of the specific experience,

qualifications, attributes or skills that led to the Board’s conclusion that the nominee should serve as a director of our company.

The Board evaluates each individual in the context of the Board as a whole, with the objective of recommending to stockholders

a group of nominees with complementary skills and a diverse mix of backgrounds, perspectives and expertise beneficial to the

broad business diversity of the company. Our board membership criteria and director nomination process are described in the

“Corporate Governance” section of this Proxy Statement.

Dr. Garth N. Graham

●
Age: 50 Director since: 2021 Independent Committees: Compensation; Technology

Carolyn B. Handlon

●
Age: 67 Director since: 2022 Independent Committees: Audit; Nominating

14 | Science Applications International Corporation | 2025 Proxy Statement

PROPOSAL 1 - ELECTION OF DIRECTORS

Yvette M. Kanouff

●
Age: 59 Director since: 2019 Independent Committees: Audit; Technology (Chair)

Timothy J. Mayopoulos

●
Age: 66 Director since: 2015 Independent Committees: Audit; Compensation; Nominating

saic.com | 15

PROPOSAL 1 - ELECTION OF DIRECTORS

Katharina G. McFarland

●
Age: 65 Director since: 2019 Independent Committees: Nominating (Chair); Technology

Milford W. McGuirt

●
Age: 68 Director since: 2021 Independent Committees: Audit (Chair); Nominating

16 | Science Applications International Corporation | 2025 Proxy Statement

PROPOSAL 1 - ELECTION OF DIRECTORS

Donna S. Morea

●
Age: 70 Director since: 2013 Independent Chair of the Board Committees: Compensation; Nominating

James C. Reagan

●
Age: 66 Director since: 2023 Independent Committees: Audit; Compensation

saic.com | 17

PROPOSAL 1 - ELECTION OF DIRECTORS

Steven R. Shane

●
Age: 67 Director since: 2013 Independent Committees: Compensation (Chair); Technology

John K. Tien, Jr.

●
Age: 61 Director since: 2024 Independent Committees: Nominating

18 | Science Applications International Corporation | 2025 Proxy Statement

PROPOSAL 1 - ELECTION OF DIRECTORS

Toni Townes-Whitley

●
Age: 61 Director since: 2023 Chief Executive Officer Committee: Technology

saic.com | 19

PROPOSAL 1 - ELECTION OF DIRECTORS

Director Skills and Qualifications

The table below summarizes some of the key skills and expertise of our director nominees. This summary is not intended to be

an exhaustive list of each of our director nominee’s skills or contributions to the Board. The absence of a mark does not mean

that a particular director does not possess that qualification or skill.

20 | Science Applications International Corporation | 2025 Proxy Statement

saic.com | 21

CORPORATE GOVERNANCE

Corporate Governance Guidelines

Our Board recognizes the importance of strong corporate governance as a means of addressing the various needs of our

stockholders, employees, customers and other stakeholders. As a result, our Board has adopted Corporate Governance

Guidelines which, together with our certificate of incorporation, bylaws, committee charters and other key governance practices

and policies, provide the framework for our corporate governance. Our Corporate Governance Guidelines cover a wide range of

subjects, including criteria for determining the independence and qualification of our directors. These guidelines are available on

our Investor Relations website at investors.saic.com by clicking on the link entitled “Corporate Governance.” The Board

recognizes that observing good corporate governance practices is an ongoing responsibility. The Nominating and Corporate

Governance Committee regularly reviews corporate governance developments and recommends revisions to these Corporate

Governance Guidelines and other corporate governance documents as necessary to promote our and our stockholders’ best

interests and to help ensure that we comply with all applicable laws, regulations and stock exchange requirements relating to

corporate governance.

Proxy Access

Our bylaws include a “proxy access” provision for director nominations under which eligible stockholders may nominate

candidates for election to our Board and inclusion in our Proxy Statement for our annual meeting of stockholders. The “proxy

access” provision provides that:

• an eligible stockholder, or an eligible group of up to 20 stockholders, representing at least 3% of our outstanding shares of

common stock,

• owning those shares continuously for at least three years,

• can nominate and include in our Proxy Statement director nominees constituting up to 25% of the Board or, if that

percentage is not a whole number, the closest whole number below 25%, but not less than two individuals, for election at our

annual meeting of stockholders.

These “proxy access” director nominees are subject to certain eligibility, procedural and disclosure requirements as further set

forth in Section 3.17 of our bylaws.

Code of Conduct

All of our employees, including our executive officers and our directors, are required to comply with our Code of Conduct, which

describes our standards for protecting company and, customer assets fostering a safe and healthy work environment, dealing

fairly with customers and others, conducting international business properly, reporting misconduct and protecting employees

from retaliation. Our Code of Conduct forms the foundation of our corporate policies and procedures designed to promote ethical

behavior in all aspects of our business.

Our Code of Conduct is available on our Investor Relations website at investors.saic.com by clicking on the link entitled

“Corporate Governance.”

Director Independence

The Board annually determines the independence of each of our directors and nominees in accordance with our Corporate

Governance Guidelines. These guidelines provide that “independent” directors are those who are independent of management

and free from any relationship that, in the judgment of the Board, would interfere with their exercise of independent judgment. No

director qualifies as independent unless the Board affirmatively determines that the director has no material relationship with us

(either directly or as a partner, stockholder or officer of an organization with which we have a relationship). The Board has

established independence standards set forth in our Corporate Governance Guidelines that include all elements of

independence required by the listing standards of The Nasdaq Stock Market LLC (“Nasdaq”).

22 | Science Applications International Corporation | 2025 Proxy Statement

CORPORATE GOVERNANCE

All members of the Audit, Human Resources and Compensation, and Nominating and Corporate Governance Committees must

be independent directors as defined under our Corporate Governance Guidelines. Members of the Audit Committee must also

satisfy a separate independence requirement pursuant to applicable Nasdaq listing standards and the Securities Exchange Act

of 1934, as amended (the "Exchange Act”), which requires that they not accept, directly or indirectly, any consulting, advisory or

other compensatory fee from us or any of our subsidiaries other than their directors’ compensation or be an affiliated person of

us or any of our subsidiaries.

Each year, our directors complete a questionnaire which requires them to disclose any transactions with us in which the director

or any member of his or her immediate family might have a direct or potential conflict of interest. Based on an analysis of the

responses, the Board determined that all directors, except for Ms. Townes-Whitley, because of her role as our Chief Executive

Officer, are independent under our Corporate Governance Guidelines and free from any relationship that would interfere with the

exercise of their independent judgment.

The Board considered the following relationships involving Hon. Deasy in reaching the conclusion that such relationship did not

interfere with the exercise of Hon. Deasy's independent judgment in his capacity as a member of the Board:

• Hon. Deasy is an advisory board member to the Director for the National Security Agency for technology improvements and

has no role in acquisition issues.

• Hon. Deasy previously served on our Advisory Board and as a consultant to the company, pursuant to a consulting

agreement entered into in May 2021. Prior to Hon. Deasy’s appointment to the Board effective as of September 8, 2023,

Hon. Deasy resigned from his position on the Advisory Board and his consulting agreement was terminated. Hon. Deasy did

not receive more than $120,000 in comp ensation from the company during any 12-month period within the three years

preceding our determination of his independence .

Further, the Board considered the following relationship involving Mr. Tien in reaching the conclusion that such relationship did

not interfere with the exercise of Mr. Tien's independent judgment in his capacity as a member of the Board:

• The Company paid Mr. Tien a $30,000 one-time fee for speaking at a Company conference last year.

Criteria for Board Membership

To fulfill its responsibility to identify and recommend to the full Board nominees for election as directors, the Nominating and

Corporate Governance Committee reviews the composition of the Board to determine the qualifications and areas of expertise

needed to further enhance the composition of the Board. In evaluating potential nominees, the Nominating and Corporate

Governance Committee and the Board consider each individual in the context of the Board as a whole, with the objective of

recommending to stockholders a slate of individual director nominees that can best continue the success of our business and

advance stockholders’ interests. In evaluating the suitability of individual nominees, the Nominating and Corporate Governance

Committee and the Board consider many factors, including:

●	expertise and involvement in areas relevant to our business such as defense, intelligence, science, finance, government or commercial and international business;
●	commitment to business ethics, professional reputation, independence and understanding of the responsibilities of a director and the governance processes of a public company;
●	demonstrated leadership, with the ability to exercise sound judgment informed by diversity of experience and perspectives; and
●	benefits from the continuing service of qualified incumbent directors in promoting stability and continuity, contributing to the Board’s ability to work together as a collective body and giving the company the benefit of experience and insight that its directors have accumulated during their tenure.

saic.com | 23

CORPORATE GOVERNANCE

The Nominating and Corporate Governance Committee reviews the director selection process annually and the Committee and

the Board collectively assess its effectiveness through an annual written evaluation process. In addition, the Nominating and

Corporate Governance Committee has been directed by the Board to observe the following principles contained in our Corporate

Governance Guidelines:

●	a majority of directors must meet the independence criteria established by the Board;
●	based upon the range of 7 to 14 directors currently specified in our bylaws, no more than three directors may be an employee of SAIC;
●	commitment to business ethics, professional reputation, independence and understanding of the responsibilities of a director and the governance processes of a public company;
●	only a full-time employee who serves as either the Chief Executive Officer or one of his or her direct reports will be considered as a candidate for an employee director position; and
●	no director nominee may be a consultant to the company.

The Board expects a high level of commitment from its members and will review a candidate’s other commitments and service

on other boards to ensure that the candidate has sufficient time to devote to the company. In addition, non-employee directors

may not serve on the board of directors of more than four other publicly-traded companies. Moreover, directors are expected to

act ethically at all times and adhere to our Code of Conduct.

Board Leadership Structure

The Board is currently led by a non-executive Chair, Ms. Morea, who is an independent director. Our Board believes that it is in

the best interests of stockholders for the Board to have the flexibility to determine the most qualified and appropriate individual to

serve as Chair of the Board, whether that person is an independent director or the Chief Executive Officer. The Board selects the

Chair annually and may decide to separate or combine the roles of Chair of the Board and Chief Executive Officer, if appropriate,

at any time in the future. In cases where the Board determines it is in the best interests of our stockholders to combine the

positions of Chair and Chief Executive Officer, the independent directors will, upon nomination and recommendation by the

Nominating and Corporate Governance Committee, elect a lead independent director with the responsibilities described in our

Corporate Governance Guidelines.

The functions of the non-executive Chair of the Board include:

●	planning the Board’s annual schedule of meetings and agendas, in consultation with the Chief Executive Officer and Corporate Secretary and other directors as appropriate;
●	coordinating with the Chief Executive Officer and the Corporate Secretary to ensure that the Board receives the appropriate quantity and quality of information in a timely manner to enable it to make informed decisions;
●	chairing all meetings of the Board and of the independent directors in executive session and ensure that meetings are conducted efficiently and effectively;
●	facilitating full and candid Board discussions, ensuring all directors express their views on key Board matters and assist the Board in achieving a consensus;
●	working with committee chairs to ensure that each committee functions effectively and keeps the Board apprised of actions taken;
●	building consensus, developing teamwork and a cohesive Board culture and facilitating formal and informal communication with and among directors; and
●	serving as the liaison between the Board and company management.

24 | Science Applications International Corporation | 2025 Proxy Statement

CORPORATE GOVERNANCE

The Board’s Role in Risk Oversight

As part of its oversight function, the Board and its committees monitor risk as part of their regular deliberations throughout the

year. When granting authority to management, approving strategies, making decisions and receiving management reports, the

Board considers, among other things, the risks facing the company. The Board also oversees risk in particular areas through its

committee structure.

The Board had the following principal standing committees during our fiscal year ended January 31, 2025 ("fiscal 2025"): Audit,

Risk Oversight, Human Resources and Compensation, and Nominating and Corporate Governance.

On March 26, 2025, the Board determined that it was in the best interests of the Company and its stockholders to reallocate the

responsibilities of the Risk Oversight Committee between the Nominating and Corporate Governance Committee and a newly

established Technology Committee that will specifically oversee the Company’s technology-related opportunities and risks. In

making these changes to the Board committee structure, the Board recognized that the Risk Oversight Committee’s discussions

over time increasingly related to the Company’s strategic opportunities and risks regarding new technologies, including issues

surrounding artificial intelligence, data management, cybersecurity, and privacy. As a result, the Board determined that a

committee of the Board focused specifically on those issues would provide for more in-depth review and oversight of the

Company’s technology-related strategic, enterprise and regulatory opportunities and risks. The Board also determined that the

Nominating and Corporate Governance Committee has the capacity and expertise to oversee the other risk, compliance and

governance responsibilities of the Risk Oversight Committee that are not being assumed by the Technology Committee,

including review of the company’s ethics, compliance and enterprise risk management programs, oversight of the Company’s

classified business, and review and approval of related party transactions. With this reallocation of responsibilities and the

creation of the Technology Committee, the Board determined to dissolve the Risk Oversight Committee effective as of March 26,

1. The Technology Committee is comprised of the following members: Yvette M. Kanouff (Chair); Garth N. Graham;

Katharina G. McFarland; Steven R. Shane; and Toni Townes-Whitley.

The charters of the Audit Committee, the Human Resources and Compensation Committee, the Technology Committee, and the

Nominating and Corporate Governance Committee are available in print to any stockholder who requests them an d are also

available on our Investor Relations website at investors.saic.com by clicking on the link entitled “Corporate Governance.”

BOARD OF DIRECTORS — Audit Committee The Audit Committee evaluates the company’s guidelines and policies regarding risk assessment and risk management, including risks related to internal control over financial reporting, the company’s major financial risk exposures and the steps management has taken to monitor and control those exposures.	Risk Oversight Committee During fiscal 2025, the Risk Oversight Committee reviewed and provided oversight of the company's regulatory, enterprise and strategic risk; ethics, compliance, and corporate responsibilities; and its classified and business operations. The Risk Oversight Committee was dissolved effective as of March 26, 2025, with such responsibilities reallocated between the Technology Committee and the Nominating and Corporate Governance Committee as of such date.	Human Resources and Compensation Committee The Human Resources and Compensation Committee assesses risks potentially arising from the company’s human resources and compensation policies and practices.	Nominating and Corporate Governance Committee The Nominating and Corporate Governance Committee identifies and recommends individuals for selection to the Board, develops and recommends corporate governance guidelines to the Board, makes recommendations regarding the size, composition and charters of the Board and oversees the evaluation of the Board and Board committees.

The company also utilizes an internal Enterprise Risk Management Committee comprised of senior management that, among

other things, works with the Chief Executive Officer, the committees of the Board and the full Board to establish the overall

saic.com | 25

CORPORATE GOVERNANCE

corporate risk strategy and oversight of policies, systems, processes and training relating to risk matters within the company. This

committee reported quarterly to the Audit and Risk Oversight Committees during fiscal 2025 and reports annually to the full

Board on its activities and findings, highlighting the key risks we face and management’s actions for managing those risks.

Corporate Responsibility

We center our corporate responsibility efforts on strong governance that ensures ethical behavior, integrity, accountability and

transparency. Integrating SAIC’s values of innovation, integrity and inclusion, we work to position SAIC as an industry leader to

better our business, our customers’ ventures, our employees’ lives and the communities in which we live and operate.

Environmental, Social and Governance

To execute our corporate responsibility and sustainability priorities, the Nominating and Corporate Governance Committee of

SAIC’s Board of Directors has oversight of the company’s ESG strategy. To further the strategy, SAIC’s ESG Council, consisting

of leaders from across the company, provides operational governance around the company’s related efforts. The ESG Council

also serves as advisors to our Executive Leadership Team and the ESG team on matters related to corporate responsibility, ESG

and sustainability. Through our formal stakeholder assessment from 2023, our material areas of impact and focus are Ethics and

Compliance; Cybersecurity, Data Security and Privacy; Corporate Culture; Employee Well-being and Talent Management; and

Corporate Governance.

Employee Engagement and Culture

In fiscal 2025, we accomplished significant advancement of our culture through inclusive internal efforts, employee development,

talent acquisition and employee engagement. In our fiscal year 2025 culture survey, we achieved our highest overall score in five

years ― exceeding the national benchmark by 6%.

We develop our leadership team from within our workforce by providing training, educational resources and leadership development

programs which are available to all. To ensure greater opportunities for all, we offer several programs that incorporate internal

networking components, provide opportunities for mentoring, upskilling and create engagement with leadership.

Third parties acknowledge our ability to foster an innovative workforce. In fiscal 2025, we received several noteworthy

recognitions including Fortune’s Sector Leaders in Technology; The Wall Street Journal & Drucker Institute 250 Best-Managed

Companies of 2024; and Forbes' America’s Best Employers for Engineers.

Giving Back to Our Workforce and Communities

As a strong corporate citizen, we build on our tradition of community engagement and philanthropy.

We invest in longer-term philanthropic support, targeting programs that address our three pillars of focus: military heroes,

community wellness, and STEM. Over the years these efforts include building 18 homes for military heroes, providing close to

28 million meals to people in need and supporting hundreds of unique STEM engagements to youth organizations nationwide.

Last year, our employees volunteered approximately 33,000 hours in support of the communities where we live and work.

An important component of this is the SAIC Foundation, a public 501(c)(3) organization to address unforeseen financial impacts

on employees and their families, providing emergency funds when financial hardships or natural disasters arise. In calendar year

2024, the Foundation awarded grants for more than $235,000 in direct support to our employees.

Being Good Stewards of the Environment

Our goal is to be a good steward of the environment by reducing and mitigating any adverse impacts on the environment.

Through our ongoing risk assessments, we have narrow exposure to environmental risks. When we identify a material risk, we

address it. As importantly, we look for opportunities to lessen our environmental impacts while balancing them with our business

priorities and routinely make business decisions that result in a more positive environmental outcome.

26 | Science Applications International Corporation | 2025 Proxy Statement

CORPORATE GOVERNANCE

Board of Directors Meetings and Committees

The Board held four meetings of the entire Board during fiscal 2025. During fiscal 2025, the independent directors met four times

for regular board meetings, and seven times for executive sessions. Ms. Morea presided as the non-executive Chair of the Board

at all Board meetings held during fiscal 2025 and at all executive sessions of our independent directors as provided by our

Corporate Governance Guidelines. During fiscal 2025, the directors attended 100% of the Board and committee meetings. All

directors are expected to attend our 2025 annual meeting of stockholders and all of the directors who were both serving at the

time of and standing for re-election at last year’s annual meeting of stockholders attended such meeting.

saic.com | 27

CORPORATE GOVERNANCE

AUDIT COMMITTEE
MEMBERS (1)(2)
●	●	●	●	●
Milford W. McGuirt (Chair)	Carolyn B. Handlon	Yvette M. Kanouff	Timothy J. Mayopoulos	James C. Reagan
Roles and Responsibilities The specific responsibilities of the Audit Committee are further set forth in its charter and include: • Internal Controls and Disclosure Controls —Review and provide feedback on management’s assessment of, and the report on, the effectiveness of the company’s internal control over financial reporting, and the independent, registered public accounting firm’s related report. • Independent Audit —Appoint, retain, oversee, evaluate, and if necessary, replace the company's independent registered public accounting firm, including the lead audit partner, for the purpose of preparing or issuing an audit report on our annual consolidated financial statements and performing other audit, review or attest services; pre-approve all audit and non-audit services and related fees; and evaluate the independent registered public accounting firm’s qualifications, performance and independence, in light of among other things, non-audit services and fees. • Internal Audit —Review the qualifications, structure and performance of the internal audit function; review and approve the company’s internal audit plan; and periodically review findings from completed audits, status of major audits in process, and any significant difficulties, disagreements with management or restrictions encountered in the scope of the company's internal audit department’s work. • Financial Reporting —Review and discuss with management, the independent registered public accounting firm and the internal auditor the company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q; and discuss with the independent registered public accounting firm the auditor’s judgments and recommendations about the accounting principles used to prepare our consolidated financial statements. • Ethical and Legal Compliance —Review the effectiveness of our system for monitoring compliance with laws and regulations; establish procedures for the receipt, retention and treatment of complaints regarding accounting, internal accounting controls or auditing matters (including procedures for receiving and handling complaints on a confidential and anonymous basis); and evaluate and handle any complaints submitted to or reported to the Audit Committee. • Other Responsibilities —Discuss and evaluate our guidelines and policies regarding risk assessment and risk management; discuss our major financial risk exposures and the steps management has taken to monitor and control those exposures; and review our litigation, government investigation and legal compliance matters that could have a significant impact on our financial statements.

Meetings

held in Fiscal

2025

4

(1) The Board has determined that each member of the Audit Committee is independent for purposes of our Corporate

Governance Guidelines, as well as for purposes of the requirements of the Exchange Act and the applicable Nasdaq

listing standards.

(2) The Board has determined that each member of the Audit Committee qualifies as an Audit Committee “financial

expert” as defined by the rules under the Exchange Act. The backgrounds and experience of the Audit Committee

financial experts are set forth above in “Proposal 1—Election of Directors.”

28 | Science Applications International Corporation | 2025 Proxy Statement

CORPORATE GOVERNANCE

RISK OVERSIGHT COMMITTEE (1)
MEMBERS (2)(3)
●	●	●	●	●
Yvette M. Kanouff (Chair)	Garth N. Graham	Katharina G. McFarland	Steven R. Shane	Toni Townes- Whitley
Roles and Responsibilities During fiscal 2025, the responsibilities of the Risk Oversight Committee included: • Monitoring and Overseeing Regulatory, Enterprise and Strategic Risk Areas, including reviewing the following: operational, compliance and reputation risk management activities; and enterprise legal and strategic risk management activities, material regulatory matters, technology oversight and cyber risk. • Monitoring and Overseeing Policies and Practices Relating to Ethics, Compliance, and Corporate Responsibility, including reviewing the following: our Code of Conduct; third-party risk; safety; environmental, sustainability and governance matters; contributions to charitable and other tax- exempt organizations; and political contributions and government relations. • Overseeing Case Management and Personal Conflict of Interest Review Process for Executive Officers and Independent Directors, including: the receipt, retention and treatment of complaints involving alleged misconduct, unethical behavior, violation of the company’s policies or potential conflict of interest involving an executive officer or any other person or matter of concern presented to the Committee by the Board. • Overseeing the Company's Classified Business, including: the general oversight of the company's classified business activities and making recommendations to the Board and management concerning the review of the strategic, operational and financial aspects of the company’s classified business; and the review of policies, processes, procedures, training, risk assessment and management activities applicable to the company’s classified business activities to the extent that they deviate from those applicable to the company’s non-classified business activities.

Meetings

held in Fiscal

2025

4

(1) The Risk Oversight Committee dissolved effective as of March 26, 2025.

(2) Hon. Deasy served on the Risk Oversight Committee for fiscal 2025 until he resigned from the Board and the

Committee effective as of January 2, 2025.

(3) For fiscal 2025, the Board determined that each member of the Risk Oversight Committee was independent for

purposes of our Corporate Governance Guidelines as well as for purposes of the Exchange Act and the applicable

Nasdaq listing standards.

saic.com | 29

CORPORATE GOVERNANCE

HUMAN RESOURCES AND COMPENSATION COMMITTEE
MEMBERS (1)(2)
●	●	●	●	●
Steven R. Shane (Chair)	Garth N. Graham	Timothy J. Mayopoulos	Donna S. Morea	James C. Reagan
Roles and Responsibilities The responsibilities of the Human Resources and Compensation Committee are further set forth in its charter and include: • Determining the compensation of our Chief Executive Officer and reviewing and approving the compensation of our other executive officers; • Reviewing and evaluating, with the Chief Executive Officer, the long-range plans for management succession; • Exercising all rights, authority and functions reserved to such committee under all of our equity, retirement and other compensation plans; • Approving and making recommendations to the Board regarding non-employee director compensation; • Preparing an annual report on executive compensation for inclusion in our proxy statement or Annual Report on Form 10-K in accordance with the rules and regulations of the SEC; and • Periodically reviewing our human resources strategy, policies and programs.

Meetings

held in Fiscal

2025

5

(1) The Board has determined that each member of the Human Resources and Compensation Committee is

independent for purposes of our Corporate Governance Guidelines as well as for purposes of the Exchange Act and

the applicable Nasdaq listing standards.

(2) The Committee’s processes and procedures for the consideration and determination of executive compensation are

discussed in further detail under “Compensation Discussion and Analysis” below.

30 | Science Applications International Corporation | 2025 Proxy Statement

CORPORATE GOVERNANCE

Role of Independent Compensation Consultant

The Human Resources and Compensation Committee has retained Frederic W. Cook & Co., Inc. ("FW Cook") as its independent

compensation consultant to assist the Committee in evaluating executive compensation programs and in setting executive officer

compensation. The consultant only serves the Human Resources and Compensation Committee in an advisory role and does

not decide or approve any compensation actions. The consultant reports directly to the Human Resources and Compensation

Committee and does not perform any services for management. The consultant’s duties include the following:

●	reviewing our total compensation philosophy, peer group and target competitive positioning for reasonableness and appropriateness;
●	reviewing our overall executive compensation program and advising the Committee on evolving trends and best practices;
●	providing independent analyses and recommendations to the Committee on directors' and executive officers’ compensation and new compensation and benefits programs that management submits to the Committee for approval; and
●	reviewing the Compensation Discussion and Analysis section of our Proxy Statement.

The consultant interacts directly with members of management only on matters under the Human Resources and Compensation

Committee’s oversight and with the knowledge and permission of the Committee. The Human Resources and Compensation

Committee has assessed the independence of FW Cook pursuant to SEC and Nasdaq rules and concluded that the firm’s work

for the Committee does not raise any conflict of interest.

Compensation Committee Interlocks and Insider Participation

None of the members of our Human Resources and Compensation Committee have, at any time, been an officer or employee of

ours. None of our executive officers currently serve, or in the past fiscal year have served, as a member of the board of directors

or compensation committee of any entity that has one or more executive officers serving on our Board or Human Resources and

Compensation C ommittee.

saic.com | 31

CORPORATE GOVERNANCE

NOMINATING AND CORPORATE GOVERNANCE COMMITTEE
MEMBERS (1)
●	●	●	●	●	●
Katharina G. McFarland (Chair)	Carolyn B. Handlon	Timothy J. Mayopoulos	Milford W. McGuirt	Donna S. Morea	John K. Tien, Jr. (2)
Roles and Responsibilities The responsibilities of the Nominating and Corporate Governance Committee are further set forth in its charter and include: • Evaluating, identifying and recommending director nominees, including nominees proposed by stockholders; • Reviewing and making recommendations regarding the composition and procedures of the Board; • Making recommendations regarding the size, composition and charters of the Board’s committees; • Developing and recommending to the Board a set of corporate governance principles, including recommending an independent director to serve as non-executive Chair of the Board or as Lead Director (as applicable); Overseeing the company's environmental, social and governance requirements, programs, goals and risks; and • Developing and overseeing an annual self-evaluation process of the Board and its committees.

Meetings

held in Fiscal

2025

4

(1) The Board has determined that each member of the Nominating and Corporate Governance Committee is

independent for purposes of our Corporate Governance Guidelines as well as for purposes of the Exchange Act and

the applicable Nasdaq listing standards.

(2) Mr. Tien was appointed to the Nominating and Corporate Governance Committee effective December 2, 2024.

32 | Science Applications International Corporation | 2025 Proxy Statement

CORPORATE GOVERNANCE

Director Nominations Process

The Nominating and Corporate Governance Committee utilizes a variety of methods for identifying and evaluating nominees for

directors. The Committee regularly assesses the Board’s current and projected strengths and needs by, among other things,

reviewing the Board’s current profile, the criteria for Board membership described on page 22 of this Proxy Statement and our

current and future needs.

To the extent that vacancies on the Board are anticipated or otherwise arise, the Nominating and Corporate Governance

Committee prepares a target candidate profile and develops an initial list of director candidates identified by the current members

of the Board, business contacts, community leaders and members of management. The Committee may also retain a

professional search firm to assist it in developing a list of qualified candidates. The Nominating and Corporate Governance

Committee also considers any stockholder recommendations for director nominees that are properly received.

The Committee then screens and evaluates the resulting slate of director candidates to identify those individuals who best fit the

target candidate profile and Board membership criteria and provides the Board with its recommendations. The Board then

considers the recommendations and votes on whether to nominate the director candidate for election by the stockholders at the

annual meeting or to appoint the director candidate to fill a vacancy on the Board.

Stockholder Nominations

Any stockholder may nominate a person for election as a director by complying with the procedures set forth in our bylaws.

Under Section 3.03 of our bylaws, in order for a stockholder to nominate a person for election as a director, the stockholder must

give timely notice to our Corporate Secretary prior to the meeting at which directors are to be elected. To be timely, notice must

be delivered to the Corporate Secretary not later than the close of business on the 90th day, nor earlier than the close of

business on the 120th day, prior to the first anniversary of the preceding year’s annual meeting. If the date of the annual meeting

is more than 30 days before or more than 70 days after such anniversary date, however, notice by the stockholder must be

delivered not earlier than the close of business on the 120th day prior to that annual meeting and not later than the close of

business on the 90th day prior to that annual meeting or the 10th day following the day on which we first publicly announce the

date of that annual meeting, whichever occurs later.

The stockholder’s notice must include certain information as further provided in Section 3.03 of our bylaws about the nominee,

the stockholder and the underlying beneficial owner, if any, including his or her respective name, age, address, occupation,

shares, rights to acquire shares, information about derivatives, hedges, short positions, understandings or agreements regarding

the economic and voting interests of the nominee, the stockholder and related persons with respect to our stock, if any, and any

other information as would be required to be disclosed in a Proxy Statement soliciting proxies for the election of the proposed

nominee. In addition, the notice must contain certain information about the stockholder proposing to nominate that person. We

may require any proposed nominee to furnish such other information as may reasonably be required to determine the eligibility of

the proposed nominee to serve as a director. A stockholder’s notice must be updated, if necessary, so that the information

submitted is true and correct as of the record date for determining stockholders entitled to receive notice of the meeting.

In addition to the requirements set forth above, stockholders who intend to solicit proxies in support of director nominees other

than the company’s nominees must comply with the additional requirements of Rule 14a-19(b) under the Exchange Act.

Mandatory Retirement Policy

The Board has adopted a mandatory retirement age of 75 for independent directors and 65 for employee directors. It is the

general policy of the Nominating and Corporate Governance Committee not to nominate candidates for re-election at any annual

stockholder meeting to be held after he or she has attained the applicable retirement age.

Board of Directors Compensation

Our director compensation program is designed to attract and fairly compensate non-employee board members for the work

required to oversee a company of SAIC's size, industry, and complexity and to align their interests with the long-term interests of

our stockholders.

The Human Resources and Compensation Committee periodically reviews the director compensation program with the

assistance of FW Cook, our independent compensation consultant and recommends to the Board the form and amount of

compensation to be provided. The director compensation described below represents the total compensation received by our

non-employee directors for their service.

saic.com | 33

CORPORATE GOVERNANCE

Our director compensation program consists primarily of a cash component and an equity component with compensation levels

informed by peer comparator group data and in recognition of the significant amount of time required of our directors in fulfilling

their duties, as well as the skill and expertise of our directors.

Cash Compensation

Our directors receive a cash retainer for their service on the Board. For fiscal 2025, the annual retainer was $125,000 and the

annual retainer for the Chair of each committee of the Board was an additional $20,000, except for the Chair of the Nominating

and Corporate Governance Committee where the annual retainer was an additional $15,000. The annual retainer for the

Independent Chair of the Board was an additional $200,000. Effective January 1, 2025, the Audit Committee Chair retainer was

increased by $5,000. These retainers are paid quarterly in advance. In addition to the cash retainers, non-employee directors

also receive $2,000 for each meeting of the Board and each committee meeting of the Board that they attend beginning with the

second meeting above the standard number of meetings over the course of a given year. We also reimburse our directors for

expenses incurred while attending meetings or otherwise performing services as a director.

Equity Compensation

Directors are eligible to receive equity awards under our equity incentive plan. For fiscal 2025, each director, other than Mr. Tien,

was granted equity awards consisting of $170,000 in value of restricted stock units ("RSUs"). In connection with his appointment

to the Board, Mr. Tien was granted a prorated equity award of $85,000 in value of RSUs. These RSUs vest on the earlier of one

year from the date of grant or on the date of the next annual meeting of stockholders following the date of grant. A director's

equity awards will become fully vested as a result of a Change in Control, Death or Disability as described in the plan. If a

director retires due to our mandatory retirement policy, the director’s equity awards continue to vest as scheduled.

Deferral Plans

Directors are eligible to defer all or any portion of their cash retainers and fees into our SAIC Deferred Compensation Plan

("Deferred Compensation Plan"). This plan is described in further detail in the “Executive Compensation — Nonqualified Deferred

Compensation” section of this Proxy Statement.

Director Compensation Table

The following table sets forth information regarding the compensation earned or paid to our directors for their service in fiscal 2025.

Name (1)	Fees earned or paid in cash ($) (2)	Stock awards ($) (3)	Total ($)
Dana S. Deasy (4)	93,750	170,000	263,750
Garth N. Graham	125,000	170,000	295,000
Carolyn B. Handlon	125,000	170,000	295,000
Yvette M. Kanouff	145,000	170,000	315,000
Timothy J. Mayopoulos	125,000	170,000	295,000
Katharina G. McFarland	140,000	170,000	310,000
Milford W. McGuirt	146,250	170,000	316,250
Donna S. Morea	325,000	170,000	495,000
James C. Reagan	125,000	170,000	295,000
Steven R. Shane	145,000	170,000	315,000
John K. Tien, Jr. (5)	41,331	85,000	126,331

(1) Ms. Townes-Whitley, our Chief Executive Officer, is not included in this table because she received no additional compensation for her

service as a director in fiscal 2025.

(2) Amounts in this column represent the aggregate dollar amount of all fees earned or paid in cash for services as a director, including annual

retainer fees, committee and chair fees and meeting fees. Directors are eligible to defer all or any portion of their cash retainers and fees

into our Deferred Compensation Plan.

34 | Science Applications International Corporation | 2025 Proxy Statement

CORPORATE GOVERNANCE

(3) Amounts in this column reflect the grant date fair value computed in accordance with stock-based compensation accounting rules (FASB

ASC Topic 718). For fiscal 2025, each director received 1,451 RSUs, other than Mr. Tien who received 704 RSUs. For more information

regarding our application of FASB ASC Topic 718, including the assumptions used in the calculations of these amounts, please refer to

Note 8 of Notes to Consolidated Financial Statements contained in our Annual Report on Form 10-K for fiscal 2025 filed with the SEC on

March 17, 2025.

(4) Hon. Deasy resigned from the Board effective as of January 2, 2025.

(5) Mr. Tien's annual fees and equity were prorated to reflect the portion of the year that he served on the Board since his appointment on

December 2, 2024.

At the end of fiscal 2025, the following non-employee directors held the corresponding number of unvested RSUs:

Name	Unvested stock units
Garth N. Graham	1,451
Carolyn B. Handlon	1,451
Yvette M. Kanouff	1,451
Timothy J. Mayopoulos	1,451
Katharina G. McFarland	1,451
Milford W. McGuirt	1,451
Donna S. Morea	1,451
James C. Reagan	1,451
Steven R. Shane	1,451
John K. Tien, Jr.	704

At the end of fiscal 2025, our non-employee directors held vested options to purchase the following number of shares of our

common stock:

Name (1)	Aggregate shares subject to outstanding options
Yvette M. Kanouff	2,006
Donna S. Morea	5,274
Steven R. Shane	5,274

(1) The Board discontinued stock option grants for non-employee directors effective as of January 1, 2020; therefore, Dr. Graham, Ms. Handlon

and Messrs McGuirt, Reagan and Tien do not hold any outstanding options. Mr. Mayopoulos and Ms. McFarland exercised remaining

options in March 30, 2022 and April 12, 2023, respectively.

Stock Ownership Guidelines and Policies

The Board believes that directors should acquire and hold shares of our stock in an amount that is meaningful and appropriate.

To encourage directors to have a material investment in our stock, the Board has adopted stock ownership guidelines that

require directors to hold shares of our stock with a value of at least five times the amount of each director's annual cash retainer.

Board members are required to hold all shares of stock acquired under our equity programs until this target value is achieved.

The sum of all shares owned outright, shares held in a trust for the benefit of the director or his/her immediate family members,

and one-half (50%) of unvested time-based RSUs count toward the required ownership. No other equity holdings count toward

meeting the ownership requirement including any unvested, unexercised stock options. In addition to these ownership

guidelines, our directors are also subject to policies that prohibit certain short-term or speculative transactions in our securities

that we believe carry a greater risk of liability for insider trading violations or may create an appearance of impropriety. Our

guidelines require directors to obtain pre-clearance from our General Counsel for all transactions in our securities. During fiscal

2025, all members of the Board were in compliance with these stock policies and have either met or are making adequate

progress toward the stock ownership guidelines.

saic.com | 35

CORPORATE GOVERNANCE

Related Party Transactions

The Board has adopted written policies and procedures for the review and approval of transactions between us and certain

“related parties,” which are generally considered to be our directors and executive officers, nominees for director, holders of five

percent or more of our outstanding capital stock and members of their immediate families. Prior to March 26, 2025, the Board

delegated to the Risk Oversight Committee the authority to review and approve the material terms of any proposed related party

transaction. Effective as of March 26, 2025, such authority was delegated to the Nominating and Corporate Governance

Committee upon the dissolution of the Risk Oversight Committee. If a proposed related party transaction involves a non-

employee director or nominee for election as a director and may be material to a consideration of that person’s independence,

the matter is also considered by the Chair of the Board.

In determining whether to approve or ratify a related party transaction, the Nominating and Corporate Governance Committee

considers, among other factors it deems appropriate, the following factors:

●	potential benefits to us;
●	the impact on a director’s or nominee’s independence or an executive officer’s relationship with or service to us; and
●	whether the related party transaction is on terms no less favorable than terms generally available to an unaffiliated third- party under the same or similar circumstances and the extent of the related party’s interest in the transaction.

In deciding to approve a transaction, the Nominating and Corporate Governance Committee may, in its sole discretion, impose

any conditions it deems appropriate on us or the related party. Any transactions involving the compensation of executive officers,

however, are to be reviewed and approved by the Human Resources and Compensation Committee. If a related party

transaction will be ongoing, the Nominating and Corporate Governance Committee may establish guidelines to be followed in our

ongoing dealings with the related party. Thereafter, the Nominating and Corporate Governance Committee will review and

assess ongoing relationships with the related party on at least an annual basis to determine whether they are in compliance with

the Committee’s guidelines and that the related party transaction remains appropriate.

We engage in transactions and have relationships with many entities, including educational and professional organizations, in

the ordinary course of our business. Some of our directors, executive officers or their immediate family members may be

directors, officers, partners, employees or stockholders of these entities. We carry out transactions with these firms on customary

terms. There were no transactions during fiscal 2025 in which any related party had a direct or indirect material interest.

Insider Trading Policy

We have adopted an insider trading policy governing the purchase, sale and other dispositions of our securities by directors,

officers, employees and other covered persons that we believe are reasonably designed to promote compliance with insider

trading laws, rules and regulations, and listing standards applicable to SAIC. It is also the policy of the company that we will not

engage in transactions in SAIC securities while in possession of material non-public information relating to the company or SAIC

securities. A copy of our insider trading policy is filed as Exhibit 19 to our Annual Report on Form 10-K for fiscal 2025, filed with

the SEC on March 17, 2025.

36 | Science Applications International Corporation | 2025 Proxy Statement

CORPORATE GOVERNANCE

Communication with the Board of Directors

Any interested party may communicate with the Chair of the Board and the Chairs of our Audit, Human Resources and

Compensation, Technology, and Nominating and Corporate Governance Committees on Board and committee related issues by

sending an e-mail to the following (as applicable):

• boardchair@saic.com;

• auditchair@saic.com;

• compensationchair@saic.com;

• techcommchair@saic.com;

• riskoversight chair@saic.com; or

• nomgovchair@saic.com.

You may also write to them or to any other director, the independent directors as a group or the Board generally at the following

address:

SAIC

Attention: Corporate Secretary

12010 Sunset Hills Road

Reston, Virginia 20190

Relevant communications will be forwarded to the recipients noted in the communication. Communications sent to the Board or

the independent directors as a group will be forwarded to the Chair of the Board.

saic.com | 37

38 | Science Applications International Corporation | 2025 Proxy Statement

PROPOSAL 2 - ADVISORY (NON-BINDING) VOTE ON EXECUTIVE COMPENSATION

PROPOSAL 2 - ADVISORY (NON-BINDING)

VOTE ON EXECUTIVE COMPENSATION

The Board unanimously

recommends a vote FOR

t his Proposal.

As required by Section 14A of the Exchange Act, we are providing our stockholders with the opportunity to vote to approve, on a

non-binding, advisory basis, the compensation of our named executive officers as disclosed in this Proxy Statement in

accordance with the compensation disclosure rules of the SEC.

We urge stockholders to read the Compensation Discussion and Analysis section ("CD&A") contained in this Proxy Statement,

which describes in detail how we closely align the interests of our named executive officers with the interests of our stockholders.

As described in the CD&A, our compensation programs are designed to:

●	pay for performance by tying a majority of an executive officer’s compensation to the attainment of financial and other performance measures that, the Board believes, promotes the creation of long-term stockholder value and positions the company for long-term success;
●	generally provide the same types of benefits for executive officers as other employees, with no pension or death benefits for executive officers;
●	target total direct compensation at the median level among companies with which we compete for executive talent;
●	enable us to recover, or “clawback,” incentive compensation if there is any material restatement of our financial results, or if an executive officer is involved in misconduct;
●	require our executive officers to own a significant amount of shares of our common stock;
●	avoid incentives that encourage unnecessary or excessive risk-taking; and
●	compete effectively for talented executives who will contribute to our long-term success.

The Human Resources and Compensation Committee and the Board believe that these programs and policies are effective in

implementing our pay for performance philosophy and achieving its goals. This non-binding, advisory stockholder vote,

commonly known as “Say-on-Pay,” gives you, as a stockholder, the opportunity to advise whether or not you approve of our

executive compensation programs and policies by voting on the following resolution:

RESOLVED, that the stockholders approve, on an advisory basis, the compensation of the named executive officers, as

disclosed pursuant to the compensation disclosure rules of the SEC, including the Compensation Discussion and Analysis,

compensation tables and any related material as set forth in this Proxy Statement.

The vote on this resolution is not intended to address any specific element of compensation; rather, the vote relates to the

compensation of our named executive officers, as described in the CD&A and Executive Compensation sections of this Proxy

Statement in accordance with the compensation disclosure rules of the SEC. The vote is advisory, which means that the vote is

not binding on the company, our Board or the Human Resources and Compensation Committee. However, as an expression of

our stockholders’ view, the Human Resources and Compensation Committee considers the vote when making future executive

compensation decisions.

At our 2024 annual meeting of stockholders, our Say-on-Pay proposal received the support of approximately 97% of the votes

cast by our stockholders. Our Board and the Human Resources and Compensation Committee believe that this vote reflected

our stockholders’ support for the decisions made with respect to the compensation of our named executive officers for our fiscal

year ended February 2, 2024.

Vote Required

The affirmative vote of a majority of the shares present or represented and entitled to vote on Proposal 2 either in person or by

proxy is required to approve the proposal. Broker non-votes are not entitled to vote on the proposal and will not be counted in

evaluating the results of the vote. Abstentions have the effect of a vote against the proposal. Shares of common stock

represented by properly executed, timely received and unrevoked proxies will be voted in accordance with the instructions

indicated thereon. In the absence of specific instructions, properly executed, timely received and unrevoked proxies will be voted

“FOR” the proposal. This advisory vote on executive compensation is non-binding.

saic.com | 39

PROPOSAL 2 - ADVISORY (NON-BINDING) VOTE ON EXECUTIVE COMPENSATION

Recommendation of the Board

The Board unanimously recommends a vote FOR the non-binding, advisory approval of the compensation of our named

executive officers, as disclosed in this Proxy Statement.

40 | Science Applications International Corporation | 2025 Proxy Statement

COMPENSATION DISCUSSION AND ANALYSIS

saic.com | 41

COMPENSATION DISCUSSION AND ANALYSIS

COMPENSATION DISCUSSION AND ANALYSIS

This Compensation Discussion and Analysis ("CD&A") provides important information about our executive compensation

philosophy and programs for fiscal 2025. In addition, this CD&A describes compensation decisions made by our Human

Resources and Compensation Committee of the Board (sometimes referred to in this CD&A as the "Committee"), which is

responsible for overseeing the compensation programs for our executive officers, including the officers named in the executive

compensation tables in this Proxy Statement (collectively, the "named executive officers" or "NEOs").

Our Named Executive Officers for Fiscal 2025

Toni Townes-Whitley Chief Executive Officer Prabu Natarajan Executive Vice President, Chief Financial Offic er Srinivas Attili Executive Vice President, Civilian Business Group Hilary L. Hageman Executive Vice President, General Counsel and Corporate Secretary David C. Ray Executive Vice President, Space and Intelligence Business Group

CD&A Table of Contents

Executive Summary	42	Other Benefits Provided in Fiscal 2025	52
Fiscal 2025 Business Highlights	42	Other Policies and Considerations	52
Compensation Philosophy and Pay Mix	43	Assessment of Risks in our Compensation Programs	52
Program Design Overview	44	Equity Award Grant Practices	53
Governance of Our Compensation Programs	44	Stock Ownership Guidelines and Stock Holding Requirements	53
Results of 2024 Stockholder Advisory Vote	45	Prohibition on Hedging or Pledging Company Stock or Purchasing “On Margin”	53
Principal Elements and Objectives of Our Compensation Program	46	“Clawback” or Compensation Recoupment Policies	54
Committee Process for Determining Compensation	47	Post-Employment Benefits	54
Components of Fiscal 2025 Compensation Programs	48	Executive Severance and Change in Control Policy	54

42 | Science Applications International Corporation | 2025 Proxy Statement

COMPENSATION DISCUSSION AND ANALYSIS

Executive Summary

Fiscal 2025 Business Highlights

In fiscal year 2025, we achieved robust financial performance, marked by solid revenue growth, strong profitability, and

significant cash generation. We progressed on our strategic pivots while maintaining solid business performance, thanks to the

unwavering dedication of our workforce. Progress towards our objectives was fueled by the execution of crucial business

initiatives, including refining our business strategy to prioritize growth while advancing the power of technology and innovation to

serve and protect our world.

Throughout fiscal 2025, we effectively executed our strategy, delivering excellence to our customers and generating value for our

shareholders. Our ability to secure solid bookings, maintain a steady book-to-bill ratio, generate solid cash flow, and achieve

organic growth highlights our fortitude in a challenging business environment, positioning us well for continued growth in fiscal

year 2026.

(1) Non-GAAP financial measure; see the Appendix to Proxy Statement for a reconciliation of such measure against the most directly

comparable GAAP financial measure.

(2) Excludes the impact from sale of receivables ($41 million) under the Master Accounts Receivable Purchase Agreement.

We stand committed to profitable growth and long-term value creation. Full year adjusted EBITDA increased to 9.5% of

revenues, compared to 9.0% in the prior fiscal year. The increase was primarily due to improved profitability across our contract

portfolio, lower incentive-based compensation expense, and lower stock-based compensation related to the restructuring and

executive transition.

Full year operating cash flow was $535 million after excluding sale of receivables. Cash flow generation is key to our shareholder

value proposition and allowed us to deliver $75 million in annual dividend payments and to repurchase $527 million in shares of

our common stock during fiscal 2025.

saic.com | 43

COMPENSATION DISCUSSION AND ANALYSIS

Total Shareholder Return ("TSR")

as of January 31, 2025

TSR for fiscal 2025 was (15%), below a broader market index and a comparable technology index fund. Over a prior three-year

period, the Company's TSR outperformed the same broader market index and ranked below the comparable technology index.

Compensation Philosophy and Pay Mix

The Company maintains a strong “pay-for-performance” compensation philosophy focused on attracting and retaining high

quality executive talent and rewarding our executive officers primarily through variable compensation. Fixed compensation (i.e.,

base salary) is set at appropriate levels to avoid competitive disadvantage and comprises the smallest portion of overall

compensation. We believe that this philosophy serves to both encourage and recognize performance excellence and helps drive

stockholder value while facilitating a sustainable fixed-cost structure.

The charts below depict approximate percentages for each element of target total direct compensation and demonstrate how

compensation is significantly weighted towards variable at-risk compensation (short-term cash incentives, performance stock

units ("PSUs"), and restricted stock units ("RSUs")). The details of all NEO compensation are provided in the "Executive

Compensation" section of this Proxy Statement.

44 | Science Applications International Corporation | 2025 Proxy Statement

COMPENSATION DISCUSSION AND ANALYSIS

Total direct compensation for NEOs is benchmarked against median levels of compensation of comparable positions in publicly

traded companies of our size and in our industry. Consistent with our pay-for-performance philosophy, actual earned

compensation varies above or below the median level based on the degree to which specific performance goals are achieved,

changes in our stock value over time and the individual performance of each NEO.

As indicated above, base salary represents a significantly smaller portion of overall compensation than variable compensation

while a more meaningful portion is allocated to annual cash incentive awards that focus executives on annual objectives

supporting our long-term strategy. The largest portion of overall compensation for our executive officers is allocated to long-term

incentives, supporting long-term value creation and aligning the interests of our executive officers with those of our stockholders.

Program Design Overview

For fiscal 2025, we maintained the short-term and long-term performance metrics used over the past several fiscal years. The

short-term plan combines revenue, adjusted EBITDA, and adjusted operating cash flow performance with an individual

leadership multiplier score. The PSUs, which are performance-based RSUs that vest and are settled at the end of a three-year

performance period. The PSUs granted to our executive officers in fiscal 2025 are directly related to the achievement of

cumulative adjusted EBITDA, cumulative adjusted operating cash flow, and relative total shareholder return ("rTSR") over a

three-year period commencing in fiscal 2025. The combination of PSUs and time-based RSUs (vesting over 3 years) provide an

appropriate balance of medium-term and long-term incentives. See the Appendix to this Proxy Statement for a reconciliation as

to how each non-GAAP performance measure is calculated as compared to the most closely comparable GAAP measure.

By aligning significant portions of NEOs’ compensation with profitable growth and operating cash flow, a substantial portion of

total compensation for our NEOs is directly linked to key metrics that we believe drive long-term sustained stockholder returns.

Based on Company performance in fiscal 2025, the calculated payout of the short-term cash portion of annual incentives was

132.3% of target, as discussed in greater detail beginning on page 49. The Committee applied an individual leadership multiplier

score with a range of 0.5 to 1.2 to the calculated annual incentive awards of the Chief Executive Officer and each other NEOs,

based upon an assessment of each executive's relative performance during the year. PSUs granted for the fiscal 2023 through

2025 performance period were earned at 134.2% of target, as discussed in greater detail on page 51.

Governance of Our Compensation Programs

Our compensation programs incorporate best practices regarding corporate governance, risk mitigation and alignment of

executive officers’ interests with stockholders’ interests. The following are key features of our compensation practices:

AT SAIC, WE ...

AT SAIC, WE DO NOT ...

Believe in pay for performance—simply put, we reward our NEOs when the company performs. Conduct an annual review by the Committee to establish a group of comparable companies to be used in compensation decisions. Review and consider feedback provided by our stockholders related to executive compensation matters. Mitigate against imprudent risk-taking through balancing features in the design of our compensation programs. Subject cash and equity-based incentive compensation to “clawback” policies if there is a restatement of our financial results for any reason or if the employee was involved in misconduct. Require significant stock ownership of our executive officers. Use an independent compensation consultant who reports directly to the Committee. Provide “double-trigger” provisions for certain change in control benefits.

Permit cash buyout or re-pricing of underwater stock options. Guarantee any bonus payouts to executive officers. Provide employment agreements for executive officers. Provide golden parachute excise tax gross-ups on change in control benefits. Permit hedging or pledging of Company stock or purchasing Company stock on margin by our executive officers. Offer defined benefit pension benefits to our executive officers or other employees. Provide excessive perquisites for executive officers.

saic.com | 45

COMPENSATION DISCUSSION AND ANALYSIS

Results of 2024 Stockholder Advisory Vote

Based on our stockholder advisory vote at our 2024 annual meeting of stockholders, commonly referred to as a "Say-on-Pay"

vote, our stockholders approved the compensation of our NEOs, with approximately 97% of stockholder votes cast in favor of our

2024 Say-on-Pay resolution. The Committee, which is composed exclusively of independent directors, views this level of support

for our executive compensation programs as indicative of broad stockholder agreement with the pay for performance philosophy

on which our executive compensation programs are premised.

We welcome feedback from stockholders regarding our executive compensation programs, which are described in more detail

below. Stockholders desiring to communicate with the Board or the Human Resources and Compensation Committee may do so

as described under "Communication with the Board of Directors" in this Proxy Statement. The Committee will continue to take

into account stockholder votes on Say-on-Pay resolutions when evaluating our compensation philosophy and making changes to

our compensation programs and practices. See “Proposal 2—Advisory (Non-Binding) Vote on Executive Compensation” in this

Proxy Statement for additional information on our 2025 Say-on-Pay resolution.

46 | Science Applications International Corporation | 2025 Proxy Statement

COMPENSATION DISCUSSION AND ANALYSIS

Principal Elements and Objectives of Our Compensation Program

The following chart summarizes the components, relevant performance measures and time frames of our compensation program

for fiscal 2025. Consistent with our philosophy of tying pay to performance, base salary represents a significantly smaller portion

of overall compensation than variable compensation. We use a combination of cash and equity incentive awards to foster and

reward performance in key areas over near-term and long-term timeframes. We discuss each component beginning on page 48.

saic.com | 47

COMPENSATION DISCUSSION AND ANALYSIS

C ommittee Process for Determining Compensation

At the beginning of each fiscal year, the Committee reviews and approves the following elements of compensation to be provided

to each of our NEOs:

●	base salary;
●	payout range for the annual cash incentive awards that may be earned for the upcoming year and the performance goals and criteria upon which the amount of the awards will be determined;
●	mix and amount of equity incentive awards to be granted to our executive officers; and
●	payout range for PSUs that may be earned for the performance period beginning in that fiscal year and the length of the performance period, goals and criteria upon which the amount of the awards for the relevant performance period will be determined.

In determining the amounts of compensation to be awarded to our NEOs, the Committee considers the Company’s overall

performance and competitive market data for our compensation peer group.

Company performance is the primary factor in determining variable compensation. The amount of any cash or

performance-based equity incentive awards to be paid upon completion of the applicable performance period is determined

based upon our achievement of short- and long-term financial goals set at the beginning of the fiscal year or performance period,

as the case may be. However, the final cash incentive award payout also reflects an individual leadership multiplier score. The

Committee retains the ability to use negative discretion to reduce payouts when appropriate.

Individual performance is a factor in setting base salaries. In determining base salaries for our NEOs, the Committee

reviews a performance assessment for each of our executive officers, as well as compensation recommendations for the NEOs

other than the Chief Executive Officer made by the Chief Executive Officer. The Committee also considers market data, analysis

and recommendations regarding executive officer compensation provided by FW Cook, its independent compensation

consultant. The NEOs do not propose their own compensation.

The Committee assesses our Chief Executive Officer's performance. In determining compensation for our Chief

Executive Officer, the Committee meets in executive session and evaluates her performance based on her achievement of

performance objectives that are established at the beginning of the fiscal year. Formal input is received from the independent

directors and the executive leadership team. The Committee also considers the Chief Executive Officer’s leadership

contributions towards the Company’s performance, including financial results, development and achievement of strategic

objectives, progress in building capability among the executive leadership team, development of a succession plan for executive

leadership and corporate governance leadership, as well as market data and analysis and recommendations provided by the

Committee’s independent compensation consultant. The Committee determines the Chief Executive Officer’s compensation and

then reviews her evaluation and compensation with the Board’s independent directors. The Chief Executive Officer does not

propose her own compensation and is not present for discussions of her performance and compensation. The Independent Chair

of the Board and the Chair of the Committee then present the Committee’s evaluation and compensation determination to the

Chief Executive Officer.

The Committee reviews our compensation peer group annually. The Committee uses peer group information as a

reference point for assessing compensation levels and practices. The Committee, with the assistance of FW Cook, annually

reviews and approves the list of companies to ensure its appropriateness. In evaluating and selecting companies for inclusion in

the peer group, the Committee targets comparably sized publicly traded information technology, consulting, defense, and

engineering companies, as well as companies with whom we compete for executive talent with similar roles and responsibilities,

which we refer to as our “compensation peer group.”

For fiscal 2025, the compensation peer group used to determine target compensation was approved by the Human Resources

and Compensation Committee in the fall 2023 committee meeting and consisted of the following 13 companies. One prior peer,

ManTech International Corp. was acquired and removed from the peer group and ICF International was added to the peer group

due to its industry fit and to provide balance to the group.

48 | Science Applications International Corporation | 2025 Proxy Statement

COMPENSATION DISCUSSION AND ANALYSIS

Booz Allen Hamilton Holding Corporation (BAH)	KBR, Inc. (KBR)
CACI International Inc (CACI)	Leidos Holdings, Inc. (LDOS)
CGI Inc. (GIB)	Maximus, Inc. (MMS)
DXC Technology Company (DXC)	Parsons Corporation (PSN)
Huntington Ingalls Industries, Inc. (HII)	Tetra Tech, Inc. (TTEK)
ICF International (ICFI)	Textron Inc. (TXT)
Jacobs Solutions Inc. (J)

The compensation peer group generally reflects companies with annual revenues between one-third to three times our estimated

revenues for the fiscal year in which the peer group is reviewed. Compensation data from two nationally-recognized, broad-

based third-party surveys provides the Committee with additional perspective regarding the competitive landscape for executive

talent. The Committee considers survey data along with the compensation peer group data when evaluating appropriate levels of

direct compensation. To be competitive in the market for our executive-level talent, we benchmark overall compensation for our

NEOs against the market median. Actual cash incentive awards paid and PSUs earned vary, consistent with our pay-for-

performance philosophy, based on pre-established performance metrics and may therefore generate realized compensation that

is higher or lower than the market median.

Components of Fiscal 2025 Compensation Programs

Base Salary

In reviewing and approving the fiscal 2025 base salaries for our NEOs, the Committee considered its independent compensation

consultant’s analysis of pay levels among the compensation peer group and survey data, which indicated that base salaries for

our NEOs were generally competitive relative to the peer group and to survey data for all executive officers. Individual base

salaries also reflect the Committee’s judgment with respect to each NEO’s roles and responsibilities, leadership skills,

performance and work experience. The Committee reviews NEOs’ base salaries annually or at the time of a promotion or a

substantial change in responsibilities based on the above-described criteria.

In fiscal 2025, base salaries for the NEOs were increased to better align their compensation with the market for comparable

positions and are summarized below.

Name	Fiscal 2025 Base Salary	Percentage Increase from Fiscal 2024 Base Salary
Toni Townes-Whitley	$1,200,000	0.0 %
Prabu Natarajan	$720,000	2.9 %
Srinivas Attili (1)	$550,000	--
Hilary L. Hageman	$575,000	4.5 %
David C. Ray	$425,000	0.8 %

(1) Mr. Attili joined the Company in fiscal 2025 and earned a prorated percentage of his annual base salary for the period from May 6, 2024

through the fiscal year end.

Annual Cash Incentive Awards

Our short-term incentive (“STI”) plan is the primary compensation element used to reward NEO accomplishments against

established business goals approved by our Committee within a given year. Our annual cash incentive awards are based upon

performance against predetermined goals for the fiscal year to encourage and reward contributions to our annual financial,

operating and strategic objectives.

saic.com | 49

COMPENSATION DISCUSSION AND ANALYSIS

Performance goals for cash incentive awards. At the beginning of each fiscal year, the Committee sets and approves

threshold, target and maximum performance goals for the upcoming year based on objective financial goals. Further, the

Committee reviews and approves the corresponding target cash incentive awards based upon the achievement of those goals.

No amount is payable for below-threshold performance. When threshold performance is met, payouts are determined on a

straight-line basis between threshold and target performance and between target and maximum performance up to a maximum

payout of 200%.

The diagram below illustrates how we determined fiscal 2025 cash incentive awards to our NEOs under our STI plan followed by

a more detailed description of the performance for fiscal 2025.

(1) EBITDA is a non-GAAP financial measure and should be read in conjunction with net income, a GAAP financial measure; see the

Management’s Discussion and Analysis of Financial Conditions and Results of Operations section in Part II, Item 7 of our Annual Report on

Form 10-K for the year ended January 31, 2025 , for further information.

Performance measures for fiscal 2025. The financial performance measures for fiscal 2025 were closely aligned with the

Company’s strategy for sustained profitable growth and long-term value creation.

For fiscal 2025, we maintained the core financial measures that we used in fiscal 2024: revenue, adjusted EBITDA, and adjusted

operating cash flow, which directly align to our overall strategy and shareholder value creation with equal weightings of 33.3%.

These metrics focus on profitable growth and strong cash generation. The financial performance measures, their relative

weightings, the threshold, target and maximum achievement levels and actual performance for our short-term incentive program

for fiscal 2025, as approved by the Committee, is reflected in the table below. For fiscal 2025, the results reflect our organic

revenue growth of 3.1% and improvement in adjusted EBITDA margins of 50 basis points.

Fiscal 2025 Short-Term Incentive Awards

Financial Measures (1)	Weight	Threshold	Target	Maximum	Actual (1)	% of Target Achieved	Payout %
Revenue	33.3 %	$7.292B	$7.542B	$7.763B	$7.479B	99.2 %	87.4 %
Adjusted EBITDA	33.3 %	$682M	$700M	$722M	$705M	100.7 %	122.7 %
Adjusted Operating Cash Flow	33.3 %	$510M	$525M	$540M	$538M	102.5 %	186.7 %
STI Award Payout Percentage							132.3 %

(1) See the Appendix to this Proxy Statement for a reconciliation as to how each adjusted non-GAAP performance measure is calculated as

compared to the most closely comparable GAAP measure.

Determination of leadership score. The score reflects performance during the fiscal year and is focused on both what and

how results were achieved based on a mix of quantitative and qualitative performance and leadership expectations with a focus

on enabling our strategic culture shifts and upholding our core values. The score range for the NEOs was expanded in fiscal

2025 to 0.5 to 1.2 (meaning that a multiplier of -50% up to +20% may apply) to allow for greater differentiation in executive

payouts to account for outsized negative or positive performance and drive greater ability to reflect leader accountability. The

final score is based upon an assessment of each executive's relative performance and is determined by the Committee for the

Chief Executive Officer and with input from the Chief Executive Officer for the other NEOs.

50 | Science Applications International Corporation | 2025 Proxy Statement

COMPENSATION DISCUSSION AND ANALYSIS

Determination of annual incentive award amounts. For fiscal 2025, the Committee set the target amount of the cash

incentive award at 150% of base salary for the Chief Executive Officer and between 80% and 100% of base salary for the other

NEOs based on applicable market data. In determining the payout level amount, the Committee applied the STI award payout

percentage (132.3% in fiscal 2025 as calculated in the table above) to the target cash incentive amount and further applied

leadership factors ranging from 0.8 to 1.2 based upon an assessment of each executive's relative performance during the year

up to the maximum payout of 200% of target. For our NEOs, the target cash incentive award amounts as a percentage of base

salary and award amounts earned in fiscal 2025 were as follows:

Name	Base Salary	STI Target as % of Base Salary	Financial Score	Cash Incentive Amount Paid
Toni Townes-Whitley	$1,200,000	150 %	132.3 %	$2,619,540
Prabu Natarajan	$720,000	100 %	132.3 %	$1,143,072
Srinivas Attili (1)	$550,000	80 %	132.3 %	$480,249
Hilary L. Hageman	$575,000	100 %	132.3 %	$836,798
David C. Ray	$425,000	80 %	132.3 %	$359,856

(1) Mr. Attili's short term incentive was prorated based on number of months worked in fiscal 2025.

Long-Term Incentive Awards

We provide equity incentive awards to our NEOs to motivate them to stay with us and build long-term shareholder value through

their future performance. We benchmark our NEOs’ long-term incentive award opportunities at the median of the competitive

market. The following forms of long-term incentive compensation were provided to our NEOs in fiscal year 2025:

●

Restricted Stock Unit (40%) Align pay and Company performance as reflected in our stock price, encourage retention of our NEOs’ services and promote continued investment by our executives in Company stock. RSUs awarded in fiscal 2025 vest over a three-year period in 33% installments at each anniversary of the grant date. Dividend equivalents on unvested RSUs accumulate in cash and are paid when and if the underlying RSUs vest.

saic.com | 51

COMPENSATION DISCUSSION AND ANALYSIS

Fiscal 2025-2027 Performance Stock Units

For fiscal 2025, 60% of the long-term incentives awarded to our NEOs were provided in the form of PSUs (valued at target

payout). The performance measures and corresponding weightings for the fiscal 2025 PSUs are as follows:

Performance Measures	Weight	Description
Cumulative Adjusted EBITDA	33.3%	Three-year cumulative goal set at the beginning of the performance period
Cumulative Adjusted Operating Cash Flow	33.3%	Three-year cumulative goal set at the beginning of the performance period
Relative Total Shareholder Return (rTSR)	33.3%	Three-year TSR performance compared to our compensation peer group. TSR is calculated based on a 30 trading day average at the beginning and end of the performance period, with dividends assumed to be reinvested as of ex-dividend date.

At the beginning of each three-year performance period, the Committee establishes the performance measures to be used for

that performance period, their weightings and the levels of performance on those measures for the entire three-year performance

period that will generate threshold, target, and maximum payouts. The number of PSUs delivered at the end of the three-year

performance cycle may range from 0% for below threshold performance to 50% for threshold performance and up to 200% for

maximum performance. When the performance threshold is met, payouts are determined on a straight line interpolation basis for

performance levels between threshold and target and between target and maximum. The final PSU payout is delivered at the

end of the three-year performance cycle.

The financial targets are closely aligned with the Company’s long-term financial strategy, and not publicly disclosed at the time of

the award issuance due to the proprietary and competitive nature of this information. For rTSR, we measure our ranking as

compared to our compensation peer group. Threshold is set at the 25th percentile, target at the 50th percentile and maximum at

the 75th percentile. For TSR, the range for payout is 0% for threshold performance to 200% for maximum performance with

payouts determined on a straight line interpolation. Final achievement and payouts for each of the above goals will be

determined and disclosed by the Committee at the conclusion of fiscal 2027.

In addition to the annual Long-Term Incentive Awards, Mr. Attili received a one-time sign-on RSU grant on June 7, 2024, with a

grant date value of $1,000,000, that vests 33% on the first, second, and third year anniversaries of the date grant. Mr. Ray

received a one-time special RSU grant on September 13, 2024, with a grant date value of $1,000,000, that will vest in full on

January 29, 2027. These awards are aimed at recruiting and retaining critical executives in the Company.

Certification of fiscal 2023-2025 PSUs. The Compensation Committee reviewed and approved performance against pre-

established targets for the fiscal 2023-2025 plan. Payout amounts for fiscal 2023-2025 performance stock units were as follows:

Fiscal 2023-2025 Performance Stock Units Payout

Performance Measures	Performance Period	Weight	Threshold 50%	Target 100%	Maximum 200%	Actual (1)	% of Target Achieved	Payout %
Cumulative Adjusted EBITDA	FY23-25	33%	$1.755B	$2.065B	$2.375B	$2.060B	99.8%	99.2%
Cumulative Adjusted Operating Cash Flow	FY23-25	33%	$1.390B	$1.737B	$2.084B	$1.865B	107.4%	136.9%
Performance Measures	Performance Period	Weight	Threshold 0%	Target 100%	Maximum 200%	Actual (1)	% of Target Achieved	Payout %
Relative Shareholder Return	FY23-25	33%	25.0%	50.0%	75.0%	66.7%	133.3%	166.7%
Share Payout Percentage								134.2%

(1) See the Appendix to this Proxy Statement for a reconciliation as to how each adjusted non-GAAP performance measure is calculated as

compared to the most closely comparable GAAP measure.

52 | Science Applications International Corporation | 2025 Proxy Statement

COMPENSATION DISCUSSION AND ANALYSIS

Other Benefits Provided in Fiscal 2025

In addition to the elements of direct compensation described above, we also provide our NEOs with the following benefits:

Health and welfare benefits. Our NEOs are entitled to participate in the health and welfare plans that we generally offer to

all of our eligible employees, which provide medical, dental, health, group term life insurance and disability benefits. We believe

that these health and welfare benefits are reasonable in scope and amount and are of the kind typically offered by other

companies against which we compete for executive talent. Additionally, our NEOs are eligible to participate in a physical health

program. The program provides the NEOs with a comprehensive medical assessment and personalized preventive strategies to

maintain and improve personal health.

Retirement benefits. Our NEOs are entitled to participate in the same defined contribution retirement plan that is generally

available to all of our eligible employees. Currently, we provide matching contributions to eligible participants’ retirement plan

accounts based on a percentage of their eligible compensation under applicable rules. The amount of contributions we made to

the retirement plan accounts of each of our participating NEOs in fiscal 2025 was $13,800 per person with the exception of Mr.

Attili and Mr. Ray. Matching contribution amounts for Mr. Attili was $13,637 and Mr. Ray does not contribute to the SAIC

Retirement Plan. The Committee believes that these contributions to this retirement program permit our NEOs to save for their

retirement in a tax-effective manner, are reasonable in scope and amount and are of the kind typically offered by other

companies against which we compete for executive talent.

Deferred compensation plan. To provide other tax-deferred means to save for retirement, we maintain the Deferred

Compensation Plan that allows our NEOs and other eligible participants to elect to defer a portion of any cash incentive awards

granted to them under our incentive plans and a portion of their eligible salary. Though the Company may make discretionary

contributions to participating NEOs, we made no contributions to NEOs’ Deferred Compensation Plan accounts for fiscal 2025.

Vested deferred balances under the Deferred Compensation Plan will generally be paid upon retirement or termination. We also have

an additional frozen deferred compensation plan. These plans are described in more detail under “Executive Compensation,

Nonqualified Deferred Compensation” below in this Proxy Statement.

Perquisites and personal benefits. We do not provide excessive perquisites or personal benefits to our NEOs. Given the

nature of our business, we believe security is necessary and generally provided to other executives within our industry. As the

safety and security of our NEOs is of utmost importance, certain security measures are provided, including physical security,

residential security, network security and dark web monitoring in response to escalating cybersecurity threats.

Other Policies and Considerations

Assessment of Risks in our Compensation Programs

In the design and oversight of our compensation programs for NEOs and all employees, each year the Committee, with

assistance from FW Cook, the Committee’s independent compensation consultant and management, assesses risks related to

our pay practices and incentive programs. The risk assessment is focused on identifying risks associated with our compensation

programs and the mix of each type of compensation element we provide to our NEOs and all employees, as well as the

measures that the Company may employ to mitigate those risks. The Committee believes that the following features of our

compensation programs effectively mitigate excessive risk-taking that could harm our value or reward poor judgment by our

NEOs or other employees:

●	short-term incentive measures are balanced among different financial measures, with goals that are intended to be achievable upon realistic levels of performance;
●	significant weighting towards long-term incentive compensation promotes long-term decision making and discourages short-term risk-taking;
●	goals are based on Company performance measures, which mitigates excessive risk-taking within any particular business operation;
●	maximum payouts are capped at levels that do not reward excessive risk-taking;
●	our compensation recoupment policies allow us to recover compensation based on financial results that are subsequently restated or if fraud or intentional misconduct is involved; and
●	our stock ownership guidelines encourage a long-term perspective.

saic.com | 53

COMPENSATION DISCUSSION AND ANALYSIS

For fiscal 2025, the Human Resources and Compensation Committee discussed and analyzed risks associated with the

Company’s compensation policies and practices for executive officers and all employees generally. The Committee did not

identify any risks arising from the Company’s compensation programs or practices that are reasonably likely to have a material

adverse effect on the Company.

Equity Award Grant Practices

The Committee is responsible for the administration of our equity incentive plans. Generally, in advance of each fiscal year, the

Committee will select predetermined dates on which equity awards will be granted to our employees, including our NEOs, during

the following fiscal year. These grant dates are selected to occur after the dates we anticipate releasing our annual or quarterly

financial results. We generally grant equity incentive awards to our directors, executive officers and all other eligible employees

on an annual basis shortly after we announce our financial results for the recently completed fiscal year. In addition to these

annual grants, the Committee predetermines four quarterly dates on which any additional equity incentive awards may be made

to eligible NEOs or other employees in connection with an offer of employment, for retention purposes or to recognize

performance. The company does not schedule its equity grants in anticipation of the release of material non-public information

(“MNPI”) nor does the company time the release of MNPI based on equity grant dates. The Committee approves all equity

awards made to our NEOs.

Stock Ownership Guidelines and Stock Holding Requirements

We encourage our employees to own our stock so that they are motivated to maximize our long-term performance and drive

sustained stock value creation. We have adopted stock ownership guidelines for our executive officers that require them to

accumulate and maintain stock holdings calculated as a multiple of their base salary, depending on their role. The sum of all

shares owned outright, shares held in a trust for the benefit of the employee or his/her immediate family members, vested stock

held in the KESDP and MSCP compensation plans, stock held in a retirement plan and one-half (50%) of unvested time-based

RSUs count toward the required ownership. No other equity holdings count toward meeting the ownership requirement including

any unvested PSUs or unvested, unexercised stock options.

POSITION	TARGET OWNERSHIP (Multiple of Base Salary)
Chief Executive Officer	5x
Other Named Executive Officers	3x

In addition to stock ownership guidelines, we also maintain a stock holding requirements policy, which mandates that executive

officers must hold 100% of the net shares acquired under our equity incentive programs until the applicable multiple of base

salary is achieved. Messrs Natarajan and Ray have satisfied their ownership goals. Ms. Hageman is expected to satisfy her

ownership goals in fiscal 2026. As Ms.Townes-Whitley was hired during fiscal year 2024 and Mr. Attili was hired in fiscal year

2025, both are making progress toward their ownership goals.

Prohibition on Hedging or Pledging Company Stock or Purchasing “On Margin”

We have established policies that prohibit all executive officers, directors and employees from engaging in any short selling and

hedging transactions in our securities that may carry a greater risk of liability for insider trading violations and also create an

appearance of impropriety. For example, with respect to our securities, our executive officers, directors and employees are not

permitted to engage in any short sales or any trading in puts, calls or other derivatives on an exchange or other organized

market. In addition, we prohibit our executive officers, directors and employees from pledging company stock as collateral for a

loan or purchasing company stock “on margin.” Further, our executive officers, directors and senior managers are required to

obtain pre-clearance from our General Counsel for all transactions in our securities.

54 | Science Applications International Corporation | 2025 Proxy Statement

COMPENSATION DISCUSSION AND ANALYSIS

“Clawback” or Compensation Recoupment Policies

We maintain a mandatory compensation recovery policy for our current and former Section 16 officers and other officers as

designated by the Human Resources and Compensation Committee to require recovery of certain incentive-based compensation

pursuant to Rule 10D-1 of the Exchange Act and the applicable stock exchange rules. This mandatory compensation recovery

policy was filed as an exhibit to our annual report on Form 10-K for the fiscal year ended February 2, 2024.

In addition (and not in lieu of the mandatory compensation recovery policy), we continue to maintain a discretionary

compensation recovery policy pursuant to which we may require executive officers and other employees who receive incentive

compensation to return cash and equity incentives if there is a required accounting restatement to correct an error in previously

issued financial statements (upon which the incentive compensation was based). If we determine that recovery is appropriate,

we will seek repayment of the difference between the incentive compensation paid and the incentive compensation that would

have been paid, if any, based on the restated financial results. This policy also gives us discretion to recover cash and equity

incentive compensation from any employee involved in fraud or intentional misconduct whether or not such conduct results in a

restatement of our financial results. In cases of fraud or misconduct, we may seek recovery of short-term cash incentives and/or

any equity compensation paid (and/or any subsequent gains realized from the sale of any underlying SAIC shares). We may

seek to recover the applicable amount of compensation from incentive compensation paid or awarded, as a reduction from future

payments of incentive compensation, or by cancellation of outstanding equity awards.

Post-Employment Benefits

We do not maintain a defined benefit or other supplemental retirement plan that would entitle our executive officers to receive

company-funded payments if they leave the Company.

Upon certain terminations of employment, including death, disability, retirement or a change in control, our employees, including

our NEOs, may be eligible for continued vesting of equity awards on the normal schedule or accelerated vesting in full or on a

pro rata basis, depending on the nature of the event and the type of award. The purpose of these provisions is to protect

previously earned or granted awards by making them available following the specified event. Because these termination

provisions are contained in our standard award agreements for all recipients and relate to previously granted or earned awards,

we do not consider these potential termination benefits as a separate item in compensation decisions for our NEOs. Our long-

term incentive plans do not provide for additional benefits or tax gross-ups. For more information about potential post-employment

benefits, see “Executive Compensation—Potential Payments upon Termination or a Change in Control” in this Proxy Statement.

Executive Severance and Change in Control Policy

None of the NEOs have employment agreements with the Company. We maintain an Executive Severance, Change in Control

and Retirement Policy which specifies the compensation and benefits payable in connection with certain termination events for

our executive officers in change in control, non-change in control, and retirement events as further described in this Proxy

Statement under “Executive Compensation—Potential Payments upon Termination or a Change in Control.” We believe that this

policy provides an important benefit to us by helping alleviate any concern the executive officers might have during a potential

change in control of our Company and permitting them to focus their attention on our business. In addition, we believe that this

policy is an important recruiting and retention tool, as many of the companies with which we compete for talent have similar

arrangements in place for their senior management.

There are no excise tax gross-up provisions authorized by the policy. This policy renews for successive one-year terms each

year, unless the Company provides notice to the eligible executive officers of either amendments to the policy or termination of

the policy or has provided notice to an individual eligible executive officer that he or she is no longer eligible for the policy no later

than November 1 of the term year. This annual term permits the Committee to review regularly the amount of benefits that would

be provided to our executive officers in connection with certain termination events and to consider whether to continue providing

those benefits.

saic.com | 55

COMPENSATION DISCUSSION AND ANALYSIS

Human Resources and Compensation Committee Report

The Human Resources and Compensation Committee has reviewed and discussed with our management the Compensation

Discussion and Analysis included in this Proxy Statement. Based upon this review and discussion, the Committee recommended

to the Board of Directors that the Compensation Discussion and Analysis be included in this Proxy Statement.

Steven R. Shane (Chair)

Garth N. Graham

Timothy J. Mayopoulos

Donna S. Morea

James C. Reagan

56 | Science Applications International Corporation | 2025 Proxy Statement

saic.com | 57

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION

Summary Compensation Table

The following table sets forth information regarding compensation earned by our NEOs. The compensation set forth below was

earned for service to SAIC during fiscal 2025, and, if applicable, during fiscal 2024 and fiscal 2023. All compensation is

disclosed, whether or not such amounts were paid in such year:

Name and principal position	Fiscal Year (1)	Salary ($)	Bonus ($) (2)	Stock awards ($) (3)	Non-equity incentive plan compensation ($) (4)	All other compensation ($) (5)	Total ($)
Toni Townes-Whitley Chief Executive Officer	2025	1,200,000		6,384,074	2,619,540	38,129	10,241,743
	2024	578,077	—	7,175,963	3,232,320	3,958	10,990,318
Prabu Natarajan Chief Financial Officer	2025	716,923	—	1,695,945	1,143,072	15,131	3,571,071
	2024	696,154	—	1,784,097	1,400,000	27,538	3,907,789
	2023	663,462	—	4,500,148	677,700	12,450	5,853,760
Srinivas Attili Executive Vice President, Civilian Business Group	2025	391,346	1,000,000	1,704,111	480,249	20,517	3,596,223
Hilary L. Hageman Executive Vice President, General Counsel and Corporate Secretary	2025	571,154	—	1,296,884	836,798	15,131	2,719,967
David C. Ray Executive Vice President, Space and Intelligence Business Group	2025	424,878	—	1,498,931	359,856	1,331	2,284,996

(1) Compensation is provided only for fiscal years for which each individual qualified as a NEO.

(2) In connection with his appointment as Executive Vice President, Civilian Business Group, Mr. Attili received a sign-on bonus of $1,000,000.

(3) Amounts shown in this column reflect the grant date fair value computed in accordance with stock-based compensation accounting rules

(FASB ASC Topic 718). The amounts shown include the aggregate grant date fair value of RSUs and PSUs. Values for the PSUs are

computed based on the target number of shares. If the maximum level of the performance conditions was achieved, the value of the fiscal

2025 PSUs included in the “Stock Awards” column would be as follows: Ms. Townes-Whitley, $7,648,128; Mr. Natarajan, $2,031,679; Mr.

Attili, $760,131; Ms. Hageman, $1,553,607; and Mr. Ray, $597,719. Amounts include Mr. Attili's sign-on award of $1,000,000 comprised of

RSUs and Mr. Rays one-time special award of $1,000,000 comprised of RSUs.

For more information regarding our application of FASB ASC Topic 718, including the assumptions used in the calculations of these

amounts, please refer to Note 8 of Notes to Consolidated Financial Statements contained in our Annual Report on Form 10-K for fiscal 2025

filed with the SEC on March 17, 2025.

(4) Amounts shown in this column represent the actual amounts paid to the NEOs under our cash incentive award program for performance in

fiscal 2025. The threshold, target and maximum payouts are shown in the “Grants of Plan-Based Awards” table under the column headed

“Estimated future payouts under non-equity incentive plan awards.”

(5) Amounts shown in this column for fiscal 2025 include matching contributions made by the Company under the SAIC Retirement Plan on

behalf of all of our NEOs with the exception of Mr. Attili and Mr. Ray of $13,800. Matching contribution amounts shown for Mr. Attili include

$13,637 and Mr. Ray does not contribute to the SAIC Retirement Plan. Amounts shown also include expenses related to the physical health

program benefits during fiscal 2025 on behalf of our NEOs as follows: Ms. Townes-Whitley, $2,100; and Mr. Attili, $5,550. Additionally,

amounts shown reflect expenses related to taxable transportation expenses and security costs which include physical security, network

security and dark web monitoring on behalf of our NEOs as follows: Ms. Townes-Whitley, $22,230, and all other NEO's, $1,331.

58 | Science Applications International Corporation | 2025 Proxy Statement

EXECUTIVE COMPENSATION

Grants of Plan-Based Awards

The annual cash incentive plan for fiscal 2025 is described in the CD&A. For services during fiscal 2025, the NEOs received two

types of equity incentive plan awards: (1) restricted stock units, and (2) performance stock units, granted on April 5, 2024 and

June 7, 2024. Annual RSU grants vest over three years. PSU grants vest subject to performance goals related to the three-year

cumulative adjusted EBITDA, cumulative adjusted operating cash flow, and relative TSR . Dividend equivalents on unvested

RSUs and PSUs accumulate in cash and are paid when and if the underlying awards vest. The following table sets forth

information regarding the cash and equity incentive awards made to our NEOs in fiscal 2025 pursuant to our 2023 Equity

Incentive Plan.

Name	Award type	Grant date	Approval date	Estimated future payouts under non equity incentive plan awards (1) — Threshold ($)	Target ($)	Maximum ($)	Estimated future payouts under equity incentive plan awards (2) — Threshold (#)	Target (#)	Maximum (#)	All other stock awards; number of shares of stock or units (#) (3)	Grant date fair value of stock and option awards ($) (4)
Ms. Townes- Whitley	Cash	—	—	900,000	1,800,000	3,600,000	—	—	—	—	—
	PSU	04/05/2024	03/28/2024	—	—	—	14,830	29,660	59,320	—	3,824,064
	RSU	04/05/2024	03/28/2024	—	—	—	—	—	—	19,773	2,560,010
Mr. Natarajan	Cash	—	—	360,000	720,000	1,440,000	—	—	—	—	—
	PSU	04/05/2024	03/28/2024	—	—	—	3,940	7,879	15,758	—	1,015,839
	RSU	04/05/2024	03/28/2024	—	—	—	—	—	—	5,253	680,106
Mr. Attili	Cash	—	—	220,000	440,000	880,000	—	—	—	—	—
	PSU	06/07/2024	04/02/2024	—	—	—	2,081	4,161	8,322	—	380,066
	RSU	06/07/2024	04/02/2024	—	—	—	—	—	—	2,774	324,003
	RSU	06/07/2024	04/02/2024	—	—	—	—	—	—	8,562	1,000,042
Ms. Hageman	Cash	—	—	287,500	575,000	1,150,000	—	—	—	—	—
	PSU	04/05/2024	03/28/2024	—	—	—	3,013	6,025	12,050	—	776,803
	RSU	04/05/2024	03/28/2024	—	—	—	—	—	—	4,017	520,081
Mr. Ray	Cash	—	—	170,000	340,000	680,000	—	—	—	—	—
	PSU	04/05/2024	03/28/2024	—	—	—	1,159	2,318	4,636	—	298,860
	RSU	04/05/2024	03/28/2024	—	—	—	—	—	—	1,545	200,031
	RSU	09/13/2024	09/10/2024	—	—	—	—	—	—	7,411	1,000,040

(1) Amounts in these columns represent the threshold, target and maximum payout amounts of cash incentive awards with actual payouts

based upon the achievement of pre-established levels of performance during fiscal 2025, as discussed in our CD&A in this Proxy

Statement. The actual amounts that were paid to our NEOs with respect to fiscal 2025 are set forth in the table entitled “Summary

Compensation Table” under the column headed “Non-equity incentive plan compensation.”

(2) Amounts in these columns represent PSUs which are subject to performance goals related to the three-year cumulative adjusted EBITDA,

three-year cumulative adjusted operating cash flow, and relative total shareholder return. Shares are issuable at the end of the three-year

performance cycle provided that the predetermined goals have been satisfied, subject to the Human Resources and Compensation

Committee’s discretion to decrease the number of shares that are ultimately issued at the end of the performance cycle.

(3) Amounts in this column represent April 5, 2024 and June 7, 2024 grants of RSUs, which vest 33% on the first, second, and third year

anniversaries of the date of grant and September 13, 2024 special retention grant of RSUs, which vests in full on January 29, 2027.

(4) Amounts represent the grant date fair value determined in accordance with FASB ASC Topic 718. These amounts do not reflect the value

that may be actually realized by the recipient and do not reflect changes in our stock price after the date of grant. The values included for

the PSUs are based on the target number of shares.

saic.com | 59

EXECUTIVE COMPENSATION

Outstanding Equity Awards at Fiscal Year-End

The following table sets forth information regarding outstanding equity awards that were held by our NEOs at the end of fiscal 2025.

Name	Grant Date	Stock awards — Number of shares of stock or units that have not vested (#) (1)	Market value of shares of stock or units that have not vested ($) (2)	Equity Incentive Plan awards; number of unearned shares, units or other rights that have not vested (#) (3)	Equity Incentive Plan awards; market or payout value of unearned shares, units or other rights that have not vested ($) (2)
Ms. Townes-Whitley	04/05/2024	19,773	2,141,020	—	—
	04/05/2024	—	—	59,320	6,423,170
	06/12/2023	16,015	1,734,104	—	—
	06/12/2023	—	—	72,064	7,803,090
Mr. Natarajan	04/05/2024	5,253	568,795	—	—
	04/05/2024	—	—	15,758	1,706,276
	04/07/2023	3,709	401,611	—	—
	04/07/2023	—	—	16,690	1,807,193
	04/01/2022	2,171	235,076	—	—
Mr. Attili	06/07/2024	8,562	927,093	—	—
	06/07/2024	2,774	300,369	—	—
	06/07/2024	—	—	8,322	901,106
Ms. Hageman	04/05/2024	4,017	434,961	—	—
	04/05/2024	—	—	12,050	1,304,774
	04/07/2023	2,968	321,375	—	—
	04/07/2023	—	—	13,352	1,445,755
	09/16/2022	3,579	387,534	—	—
Mr. Ray	09/13/2024	7,411	802,463	—	—
	04/05/2024	1,545	167,293	—	—
	04/05/2024	—	—	4,636	501,986
	04/07/2023	1,052	113,911	—	—
	04/07/2023	—	—	3,154	341,515
	04/01/2022	589	63,777	—	—

(1) Information in this column relates to RSUs held by our NEOs at the end of fiscal 2025. All RSUs except the RSUs granted on September 13,

2024 vest annually over a three-year period at each anniversary of the grant date. The September 13, 2024 award will vest in full on

January 29, 2027.

(2) Based on $108.28 per share, the closing sales price of our common stock on Nasdaq on January 31, 2025.

(3) The number of PSUs reflected in this column represent the PSUs awarded for the fiscal 2024-2026 and fiscal 2025-2027 performance

cycles. The number of PSUs that can be earned has been disclosed in this column at a maximum payout based on performance through

January 31, 2025. The PSUs are not settled until after the performance period when performance results are certified by the Human

Resources and Compensation Committee .

60 | Science Applications International Corporation | 2025 Proxy Statement

EXECUTIVE COMPENSATION

Option Exercises and Stock Vested

The following table sets forth information regarding shares of common stock acquired by our NEOs during fiscal 2025 upon the

vesting of RSUs and the vesting of fiscal 2023-2025 PSUs.

Name	Stock awards — Number of shares acquired on vesting (#) (1)	Value realized on vesting ($) (2)
Ms. Townes-Whitley	8,007	934,737
Mr. Natarajan	47,053	5,317,300
Mr. Attili	—	—
Ms. Hageman	5,061	685,482
Mr. Ray (3)	4,911	585,127

(1) Includes PSUs earned in connection with the PSU for the fiscal 2023-2025 performance period and a portion of time-based RSUs granted

during previous fiscal years.

(2) Value realized on vesting disclosed above is based on the closing price of our common stock on Nasdaq on the vest date. For the earned

fiscal 2023-2025 PSUs, the value is based on the closing price per share of our common stock on Nasdaq on the vesting date of January

31, 2025 of $108.28.

(3) The FY23-25 PSU grant for Mr. Ray was subject to different performance conditions under a non-NEO plan (Cumulative Adjusted EBITDA

and Cumulative Adjusted Operating Cash Flow each weighted 50%; Relative TSR performance applied as a modifier) with a final share

payout percentage of 133.8%.

Nonqualified Deferred Compensation

The Deferred Compensation Plan became effective January 1, 2015 and is a pre-tax savings plan that allows eligible

participants, which includes our NEOs, to defer up to 80% of their salary and cash bonus compensation as well as director cash

retainer and meeting fees. Deferrals into the Deferred Compensation Plan are not included as eligible compensation for the

calculation of the company match in the SAIC Retirement Plan. If there is a loss of company match in the SAIC Retirement Plan

because of a deferral into the Deferred Compensation Plan, the Company may, at its sole discretion, make up the difference in

company matching contribution to the Deferred Compensation Plan. Participants elect to have deferred balances paid on a

specific date while they are still employed or upon retirement or separation of service in the form of a lump sum payment or in

annual installments over five, 10, or 15 years.

The following table sets forth information regarding deferrals under and aggregate earnings and withdrawals in fiscal 2025

through our nonqualified deferred compensation plans in which the NEOs participated. There were no company matching

contributions made to the NEOs’ accounts under any of the plans in fiscal 2025.

Name (1)	Plan	Executive contributions in fiscal 2025 ($) (2)	Aggregate earnings in fiscal 2025 ($) (3)	Aggregate withdrawals/ distributions in fiscal 2025	Aggregate balance at fiscal year-end ($) (4)
Mr. Natarajan	Deferred Compensation Plan	423,385	61,462	—	865,980
Mr. Ray	Deferred Compensation Plan	221,545	81,025	—	734,119

(1) Ms. Townes-Whitley, Mr. Attili, and Ms. Hageman are not included in this table because they have not participated in any nonqualified

deferred compensation plans.

(2) Amounts in this column include salary deferrals in fiscal 2025 and annual incentive bonus paid in fiscal 2025 for fiscal 2024 performance.

For Mr. Natarajan, $143,385; and Mr. Ray, $104,585 of this amount is reported as fiscal 2025 compensation in the Summary Compensation

Table.

(3) With respect to the Deferred Compensation Plan, amounts in this column represent aggregate returns on the investments elected by

participants from the diverse investment options available to participants under the plans. Participants may change their investment

elections at any time. The returns on the investment options available to eligible participants during fiscal 2025 ranged from 1.00% to

25.07%. T he amounts in this column are not included in the Summary Compensation Table.

(4) A mounts in this column represent the value of the holders’ accounts at the end of fiscal 2025, which includes the following amounts reported

in the Summary Compensation Table for the amounts contributed by the plan holder for the prior year: Mr. Natarajan, $280,000; and Mr.

Ray, $116,960.

saic.com | 61

EXECUTIVE COMPENSATION

Potential Payments upon Termination or a Change in Control

We have an Executive Severance, Change in Control and Retirement Policy (“Severance Policy”) that applies to designated

eligible officers, including all of our active NEOs, which became effective as of September 5, 2023 and which provides certain

benefits to the active NEOs upon their termination of employment under the circumstances described below, including in

connection with a change in control or retirement. In addition, our Amended and Restated 2013 Equity Incentive Plan (“2013

Plan”) and the award agreements thereunder, as well as the 2023 Equity Incentive Plan (“2023 Plan”) provide for accelerated

vesting and exercisability of equity awards under the circumstances described below, including in connection with a change in

control (or in the case of the 2023 Plan, upon certain terminations in connection with a change in control).

Severance Policy. Severance benefits under the Severance Policy are conditioned on the NEO signing and not revoking a

general waiver and release and signing and complying with a two-year non-compete agreement.

Under the Severance Policy, if within 90 days preceding or 21 months following a change in control an active NEO is involuntarily

terminated by the Company for any reason other than for cause, death, or disability or resigns for good reason, he or she will be

entitled to receive a lump sum cash payment equal to two times (or three times in the case of our chief executive officer) the sum

of (i) the executive officer’s then current annual base salary and (ii) the target annual incentive bonus for the fiscal year in which

the termination occurs. If the executive officer’s annual base salary was higher during the 90-day period prior to the change in

control, that higher amount will be used to determine the amount of the lump sum cash payment to which the executive officer is

entitled. The executive officer is also entitled to receive a lump sum cash payment in an amount equal to 24 months (or 36

months in the case of our chief executive officer) of the monthly COBRA premium for continued group medical coverage for the

executive officer and his or her eligible dependents, outplacement services for a period of 12 months and up to a maximum of

$25,000, and a lump sum cash payment equal to a pro-rata portion of the executive's target annual bonus opportunity for the

bonus cycle in which the termination occurs. For a change of control related termination, the NEO's outstanding equity awards

will be governed by the terms of the 2013 Plan or 2023 Plan, as applicable.

Under the terms of the Severance Policy, if, other than during the period before or after a change in control as described above,

an active NEO is involuntarily terminated by the Company for any reason other than for cause, death or disability, he or she will

be entitled to receive a lump sum cash payment equal to 1.5 times (or two times in the case of our chief executive officer) the

sum of (i) the executive officer’s then current annual base salary and (ii) the average of the most recent three actual annual cash

bonuses paid (or the average of all of the actual annual cash bonuses paid for such shorter time if the executive officer has not

been employed by us for at least three annual bonus cycles). The executive will continue to vest in all previously granted equity

awards under the 2013 Plan or 2023 Plan per the original terms of the award, but without any minimum holding period

requirements and without any proration of the award. The executive officer is also entitled to receive a lump sum cash payment

in an amount equal to 18 months (or 24 months in the case of our chief executive officer) of the monthly COBRA premium for

continued group medical coverage for the executive officer and his or her eligible dependents, outplacement services for a period

of 12 months and up to a maximum of $25,000, and a lump sum cash payment equal to a pro-rata portion of the executive's

annual bonus opportunity for the bonus cycle in which the executive's termination occurs to be paid per the Company's usual

payment schedule at the percentage payable per the Company's fiscal year annual financial performance goal attainment. After

the COBRA eligibility period has expired, the executive may elect to remain on or join the SAIC health care plan in a retiree rate

pool until Medicare eligible at the executive’s expense.

Under the terms of the Severance Policy, if an active NEO intends to retire and provides the Company with at least six months

advanced written notice of their termination and agrees to sign a two-year non-compete agreement, he or she will be entitled to

receive a lump sum cash payment in an amount equal to 18 months (or 24 months in the case of our chief executive officer) of

the monthly COBRA premium for continued group medical coverage for the executive officer and his or her eligible dependents

and a lump sum payment equal to a pro-rata portion of the executive's annual bonus opportunity for the bonus cycle in which the

executive's retirement occurs to be paid per the Company's usual payment schedule at the percentage payable per the

Company's fiscal year annual financial performance goal attainment. After the COBRA eligibility period has expired, the executive

may elect to remain on or join the SAIC health care plan in a retiree rate pool until Medicare eligible at the executive’s expense.

The executive will continue to vest in all previously granted equity wards under the 2013 Plan or 2023 Plan per the original terms

of the award, but without any minimum holding period requirements and without any proration of the award.

The Severance Policy generally defines a termination for “cause” if the termination is on account of the officer’s (i) conviction, or

entering a plea of no contest, committing an act of fraud, embezzlement, theft or other felony, (ii) willful engagement in illegal

conduct or gross misconduct that is significantly injurious to the Company, or (iii) failure to perform employment duties in a

reasonably satisfactory manner after notice from the Company and, if the failure is capable of being cured, a 30-day opportunity

to cure the failure. A resignation is generally defined to be for “good reason” if it is due to (i) a material adverse change in

authority, duties or responsibilities (including if following a change of control the executive officer is no longer an executive), (ii) a

material reduction in base salary or target bonus or any failure to pay the NEO any compensation to which the NEO is entitled

within 15 days after the date when due, or (iii) a relocation of the individual’s principal place of employment of more than 50

miles, and the Company has failed to remedy the event or condition after receiving notice of the same. The Severance Policy

defines a “change in control” in the same manner as the term is defined in our 2023 Plan, as described below.

62 | Science Applications International Corporation | 2025 Proxy Statement

EXECUTIVE COMPENSATION

The Severance Policy provides that in the event that Internal Revenue Code Section 280G excise taxes may be payable by an

executive, the executive will either receive payment in full, or have their payments cut-back to the largest amount which will avoid

excise taxes, depending on which option results in receipt of the greatest amount of severance benefits by the executive on an

after-tax basis.

The Severance Policy automatically renews on December 31 of the applicable year for the following year, unless, prior to a

“change in control” and not later than November 1 of such year, the Severance Policy is amended or terminated, and participants

are provided notice.

Equity Awards Under the 2013 Plan. Under our 2013 Plan, the vesting of stock option and RSU awards will accelerate in

full if the successor entity in a change in control does not assume or replace outstanding awards or, if such awards are assumed

or replaced, and the award recipient’s employment ends within 18 months after the change in control due to termination without

cause or resignation for good reason. The award agreements for PSUs issued under our 2013 Plan provide that if a change in

control occurs before the end of a performance period, the performance period will be terminated and an award recipient will be

entitled to receive, immediately prior to the change in control, a number of shares equal to the number determined by the

committee to have been earned for each fiscal year in the performance period completed before the change in control, plus a pro

rata portion of the shares determined by the committee to have been earned during the year in which the change in control occurred.

The 2013 Plan generally defines a “change in control” as (i) a merger or consolidation in which the Company is not the surviving

corporation, (ii) a merger in which the Company is the surviving corporation but after which the Company’s pre-merger

shareholders no longer own their Company shares, (iii) a sale of substantially all of the Company’s assets, or (iv) the acquisition,

sale or transfer of more than 50% of the Company’s outstanding shares by tender offer or similar transaction. “Cause” for

termination is generally defined in the 2013 Plan as employment-related dishonesty, fraud or misconduct likely to cause significant

injury to the Company or its personnel, and “good reason” is defined in a manner similar to that under the Severance Policy.

Other than in the context of a change in control, RSU awards and option awards will vest in full immediately if employment ends

due to death or disability, and, under those circumstances, options will remain exercisable for a period of time, which under the

2013 Plan is until the expiration date of the option award. Our PSU agreements provide that if employment ends due to death, an

award recipient’s estate will be entitled to promptly receive a number of shares determined in the same manner as if a change in

control had occurred on the date of death. If employment ends due to disability, after the completion of the first fiscal year of the

performance period, a pro rata portion (based on the portion of the performance period completed prior to the employment

termination) of the performance stock units determined to have been earned at the end of the three-year performance period will

be paid out after the end of the performance period.

Under our Special Retirement eligibility provisions as described in the award agreement(s), employees who retire, including our

NEOs, may continue vesting in their stock option awards if they have held those options for at least 12 months prior to retirement

and they retire (i) after age 59 1/2 with at least ten years of service or (ii) after age 59 1/2 when age at termination plus years of

service equals at least 70. Our executive officers who retire after reaching the applicable mandatory retirement age, however, will

be allowed to continue to vest in their option awards without regard to the 12 month holding requirement. Under the same

conditions, executive officers may continue vesting in their RSU awards, and may receive the same pro rata payout of PSUs as

applies in the event of a termination due to disability. We have the right to terminate continued vesting if a retiree violates

confidentiality, non-solicitation or similar obligations to us.

In any other termination scenario involving an equity award recipient, including a NEO, the 2013 Plan provides that all unvested

RSUs, options and PSUs are forfeited. Under these circumstances, vested options remain exercisable for 90 days or until the

option expiration date, if earlier. However, as noted above, the Severance policy allows designated eligible officers, including all

of our active NEOs, to continue vesting in their equity awards if the executive officer is involuntarily terminated without cause or

as a result of their retirement.

Equity Awards Under the 2023 Plan. Under our 2023 Plan, upon the occurrence of an award recipient’s termination of

employment by the Company for any reason (other than cause, death, or disability) or upon the recipient’s resignation for good

reason, in each case, within 18 months of a change in control, any outstanding awards that are subject to a time-based vesting

condition will accelerate and vest in full. The 2023 Plan provides that if a change in control occurs before the end of a

performance period, the performance period will be terminated and an award recipient will be entitled to receive, immediately

prior to the change in control, a number of shares equal to the number determined by the committee to have been earned for

each fiscal year in the performance period completed before the change in control, plus a pro rata portion of the shares

determined by the committee to have been earned during the fiscal year in which the change in control occurred.

The 2023 Plan generally defines a “change in control” as (i) a merger or consolidation in which the Company is not the surviving

corporation, (ii) a merger in which the Company is the surviving corporation but after which the Company’s pre-merger

shareholders no longer own their Company shares, (iii) a sale of substantially all of the Company’s assets, or (iv) the acquisition,

sale or transfer of more than 50% of the Company’s outstanding shares by tender offer or similar transaction. “Cause” for

termination is generally defined in the 2023 Plan as employment-related dishonesty, fraud, misconduct or disclosure or misuse of

confidential information that is likely to cause significant injury to the Company or its personnel, and “good reason” is defined in a

manner similar to that under the Severance Policy.

saic.com | 63

EXECUTIVE COMPENSATION

Other than in the context of a change in control, RSU awards will vest in full immediately if employment ends due to death or

disability. Our PSU agreements provide that if employment ends due to death, an award recipient’s estate will be entitled to

promptly receive a number of shares determined in the same manner as if a change in control had occurred on the date of death.

If employment ends due to disability, a pro rata portion (based on the portion of the performance period completed prior to the

employment termination) of the performance stock units determined to have been earned at the end of the three-year

performance period will be paid out after the end of the performance period.

Under our Special Retirement eligibility provisions as described in the award agreement(s), employees who retire, including our

NEOs, may continue vesting in their RSU awards if they have held those RSUs for at least 12 months prior to retirement and

they retire (i) after age 59 1/2 with at least ten years of service or (ii) after age 59 1/2 when age at termination plus years of

service equals at least 70. Under the same conditions, executive officers may receive the same pro rata payout of PSUs as

applies in the event of a termination due to disability. We have the right to terminate continued vesting if a retiree violates

confidentiality, non-solicitation or similar obligations to us. In addition, as noted above, the Severance Policy allows designated

eligible officers, including all of our active NEOs, to continue vesting in their equity awards if the executive officer is involuntarily

terminated without cause or as a result of their retirement.

In any other termination scenario involving an equity award recipient, including a NEO, the 2023 Plan provides that all unvested

RSUs and PSUs are forfeited.

Estimated Termination and Change in Control Payments and Benefits. The following table sets forth our estimates

of the payments and benefits to be made to our NEOs under various termination and change in control scenarios. In calculating

the amounts set forth in the table, we have assumed that (i) the date of termination was January 31, 2025, the last business day

of fiscal 2025, (ii) the date of any related change in control was the same date, and (iii) the price of our common stock was

$108.28 per share, the closing market price of our common stock on the Nasdaq on January 31, 2025. The table does not reflect

payments and benefits that are provided on a non-discriminatory basis to salaried employees generally upon termination, nor

does it reflect amounts attributable to equity-based awards that were already vested, or distributions of plan balances under our

nonqualified deferred compensation plan.

64 | Science Applications International Corporation | 2025 Proxy Statement

EXECUTIVE COMPENSATION

Name	Without Cause Termination (not in connection with a Change in Control) ($)	Without Cause or With Good Reason Termination (in connection with a Change in Control) (1) ($)	Retirement ($)	Death ($)	Disability ($)
Ms. Townes-Whitley
Bonus (2)	1,800,000	1,800,000	1,800,000	—	—
Severance (3)	8,864,640	9,000,000	—	—	—
Medical coverage continuation (4)	40,043	60,065	40,043	—	—
Outplacement services (5)	25,000	25,000	—	—	—
Restricted stock units (6)	3,932,626	3,932,626	3,932,626	3,932,626	3,932,626
Performance stock units (7)	7,226,043	3,735,860	7,226,043	3,735,860	3,735,860
Applicable cut back (8)	—	—	—	—	—
Total	21,888,352	18,553,551	12,998,712	7,668,486	7,668,486
Mr. Natarajan
Bonus (2)	720,000	720,000	720,000	—	—
Severance (3)	2,486,050	2,880,000	—	—	—
Medical coverage continuation (4)	55,215	73,260	55,215	—	—
Outplacement services (5)	25,000	25,000	—	—	—
Restricted stock units (6)	1,229,754	1,229,754	1,229,754	1,229,754	1,229,754
Performance stock units (7)	1,787,094	904,101	1,787,094	904,101	904,101
Applicable cut back (8)	—	—	—	—	—
Total	6,303,113	5,832,115	3,792,063	2,133,855	2,133,855
Mr. Attili
Bonus (2)	440,000	440,000	440,000	—	—
Severance (3)	1,485,000	1,980,000	—	—	—
Medical coverage continuation (4)	34,195	45,593	34,195	—	—
Outplacement services (5)	25,000	25,000	—	—	—
Restricted stock units (6)	1,235,851	1,235,851	1,235,851	1,235,851	1,235,851
Performance stock units (7)	453,632	151,211	453,632	151,211	151,211
Applicable cut back (8)	—	—	—	—	—
Total	3,673,678	3,877,655	2,163,678	1,387,062	1,387,062
Ms. Hageman
Bonus (2)	575,000	575,000	575,000	—	—
Severance (3)	1,886,756	2,300,000	—	—	—
Medical coverage continuation (4)	37,414	49,885	37,414	—	—
Outplacement services (5)	25,000	25,000	—	—	—
Restricted stock units (6)	1,167,826	1,167,826	1,167,826	1,167,826	1,167,826
Performance stock units (7)	1,399,243	713,137	1,399,243	713,137	713,137
Applicable cut back (8)	—	—	—	—	—
Total	5,091,239	4,830,848	3,179,483	1,880,963	1,880,963
Mr. Ray
Bonus (2)	340,000	340,000	340,000	—	—
Severance (3)	1,179,670	1,530,000	—	—	—
Medical coverage continuation (4)	55,215	73,620	55,215	—	—
Outplacement services (5)	25,000	25,000	—	—	—
Restricted stock units (6)	1,157,022	1,157,022	1,157,022	1,157,022	1,157,022
Performance stock units (7)	428,408	201,083	428,408	201,083	201,083
Applicable cut back (8)	—	(92,480)	—	—	—
Total	3,185,315	3,234,245	1,980,645	1,358,105	1,358,105

(1) The change in control consequences for PSUs are the same whether or not a qualifying termination (involuntary termination without cause

or resignation for good reason) occurs in connection with the change in control. With respect to option and RSU awards, the 2013 Plan also

provides for accelerated vesting and exercisability of the awards if the successor corporation does not assume or replace the awards in

connection with the change in control and the 2023 Plan provides for accelerated vesting upon a qualifying termination in connection with a

change in control.

saic.com | 65

EXECUTIVE COMPENSATION

(2) In the case of termination involuntarily without cause, in connection with a change in control, the NEOs receive a pro rata portion of their

target bonus. In case of retirement the NEOs receive a pro rata portion of the actual bonus. However, because the assumed termination

date of January 31, 2025 is the last day of the fiscal year, this column reflects the target bonus amounts of the date of termination.

(3) I n the case of a qualifying termination not in connection with a change in control, severance amounts represent a single lump sum payment

equal to two times for Ms. Townes-Whitley and 1.5 times for all other NEOs the sum of (a) the NEO's fiscal 2025 base salary and (b) the

average of the annual bonuses paid for fiscal 2024, 2023 and 2022 (or such shorter period, where applicable). In the case of a qualifying

termination in connection with a change in control, severance amounts represent a single lump sum payment equal to three times for Ms.

Townes-Whitley and two times for all other NEOs of the sum of (a) the NEO's fiscal 2025 base salary and (b) his or her target annual bonus

for fiscal 2025.

(4) In the case of a qualifying termination not in connection with a change in control, these amounts represent a lump sum cash payment

of COBRA benefits for 24 months for Ms. Townes-Whitley and 18 months for all other NEOs. In the case of a qualifying termination in

connection with a change in control, these amounts represent a lump sum cash payment of COBRA benefits for 36 months for

Ms. Townes-Whitley and 24 months for all other NEOs. This payment is made without regard to whether the NEO is participating in the

Company’s medical coverage post termination.

(5) These amounts represent the maximum value to the NEO of outplacement counseling services to be provided for 12 months following a

qualifying termination.

(6) These amounts represent the value of RSUs issued under the 2013 Plan or 2023 Plan, as applicable, that were held by the NEO at the end

of fiscal 2025 and whose vesting and payment was accelerated in connection with a change in control, death, or disability or whose vesting

continues without an employment requirement as a result of involuntary termination without cause, retirement, or termination due to death or

disability. The value was calculated by multiplying the number of RSUs whose vesting or payment was accelerated or continued by the

closing market price per share of our common stock on the Nasdaq on January 31, 2025, and includes accrued dividend equivalents as of

January 31, 2025. For more information regarding the number of unvested or unpaid RSUs held by each of the NEOs, see the table under

the caption "Outstanding Equity Awards at Fiscal Year-End."

(7) These amounts represent the value of shares underlying outstanding PSUs issued under the 2013 Plan or 2023 Plan that were held by the

NEO at the end of fiscal 2025 and whose vesting was accelerated or continued in connection with a change in control, involuntary

termination without cause, retirement, termination due to disability, or termination due to death. For PSUs in this table, the value was

calculated by multiplying the number of performance stock units whose vesting was accelerated or continued by the closing market price

per share of our common stock on the Nasdaq on January 31, 2025, and includes accrued dividend equivalents as of January 31, 2025. For

an involuntary termination without cause or retirement under the Severance Policy, the performance stock units earned are determined at

the end of the three-year performance period and are paid at the end of that performance period. For a termination following a change of

control or death, the PSU performance period will be terminated and an award recipient will be entitled to receive, immediately prior to the

change in control, a number of shares equal to the number determined by the committee to have been earned for each fiscal year in the

performance period completed before the change in control, plus a pro rata portion of the shares determined by the committee to have been

earned during the fiscal year in which the change in control occurred. For a termination due to disability, a pro rata portion (based on the

portion of the performance period completed prior to the employment termination) of the performance stock units determined to have been

earned at the end of the three-year performance period will be paid out after the end of the performance period. In this table PSUs are

assumed earned and calculated at 100.0% of target for all fiscal years within a performance period. Note that PSUs from fiscal 2023 are not

included in this table since they are deemed to be earned as of January 31, 2025.

(8) Under the Severance Policy, executives either receive (a) payment in full, or (b) have their payments cutback to avoid excise taxes payable

pursuant to Sections 280G and 4999 of the Internal Revenue Code, depending on which option results in receipt of the greatest amount of

severance benefits by the executive on an after-tax basis. The amount reported under this item is the amount by which NEO's payment

would be reduced if necessary to avoid paying excise taxes because such reduction results in a larger payment than if the excise tax was

triggered.

66 | Science Applications International Corporation | 2025 Proxy Statement

EXECUTIVE COMPENSATION

CEO Pay Ratio

We are providing the following information about the relationship of the annual median total compensation of our employees and

the annual total compensation of Toni Townes-Whitley, our CEO at the end of fiscal 2025.

We identified the median employee employed as of December 31, 2024 as follows:

• We collected data for all employees (excluding the CEO), including part-time and full-time, permanent, temporary and

seasonal employees, and excluding independent contractors.

• We used base pay as our consistently applied compensation measure.

• We identified employees within a narrow range of the estimated median and then employed statistical sampling to select the

median employee from within that range.

We then determined our median employee’s total compensation, including any perquisites and other benefits, in the same

manner that we determine the total compensation of our NEOs for purposes of the Summary Compensation Table disclosed

above. The median employee's total compensation in fiscal 2025 was comprised of base salary and 401(k) plan contributions.

Based on the above calculations, for fiscal 2025, our last completed fiscal year:

• the annual total compensation of the median employee was $115,783; and

• the total compensation of our CEO was $10,241,743

Therefore, we reasonably estimate that the ratio of our CEO’s annual total compensation to the annual total compensation

of our median employee was 88:1. Our pay ratio estimate has been calculated in a manner consistent with item 401(u) of

Regulation S-K.

Pay Versus Performance

The following table and supporting graphics below set out information about the relationship between executive compensation

actually paid and the Company's financial performance for the five fiscal years in satisfaction of Item 402(v) of Regulation S-K.

The below table presents compensation actually paid ("CAP") to our principal executive officer ("PEO") and (on average) to our

other NEOs ("non-PEOs") during the specified fiscal years alongside summary compensation table ("SCT") totals, total

shareholder return (for the Company and a peer group), net income and the Company selected measure of revenue. The

Company selected this measure as the most important measure used in the last fiscal year to link CAP to our executives and our

performance. This measure is a key metric in the short-term incentive plan for our executives, representing 33% of the target

opportunity as found on page 46.

Fiscal Year (1)	Summary Compensation Table Total for First PEO (Keene) ($)	Compensation Actually Paid to First PEO (Keene) (2)(3)(4) ($)	Summary Compensation Table Total for Second PEO (Townes- Whitley) ($)	Compensation Actually Paid to Second PEO (Townes- Whitley) (2)(3)(4) ($)	Average Summary Compensation Table Total for Non-PEO NEOs ($)	Average Compensation Actually Paid to Non-PEO NEOs (2)(3)(4) ($)	Total Shareholder Return (5)	Peer Group Total Shareholder Return (5)	Net Income ($ in millions) (6)	Revenue ($ in millions) (7)
2025	—	—	10,241,743	8,432,362	3,043,064	2,628,442	132.94	195.26	362	7,479
2024	12,895,917	18,951,966	10,990,318	13,473,423	4,541,334	6,387,422	156.53	153.18	477	7,444
2023	8,664,380	13,290,774	—	—	4,681,658	5,523,501	124.66	119.29	303	7,704
2022	8,343,156	6,384,092	—	—	2,563,133	2,239,947	95.92	121.59	279	7,394
2021	6,936,702	9,060,542	—	—	1,945,432	2,322,465	111.36	106.52	211	7,056

(1) Our PEO and Non-PEO NEOs included in the above compensation columns reflect the following:

saic.com | 67

EXECUTIVE COMPENSATION

Fiscal Year	PEOs	Non-PEO NEOs
2025	Toni Townes- Whitley	Prabu Natarajan, Srinivas Attili, Hilary L. Hageman, David C. Ray
2024	Nazzic S. Keene; Toni Townes- Whitley	Prabu Natarajan, Robert S. Genter, Michael W. LaRouche, Michelle O’Hara
2023	Nazzic S. Keene	Prabu Natarajan, Robert S. Genter, Michael W. LaRouche, Michelle O’Hara, Steven G. Mahon
2022	Nazzic S. Keene	Prabu Natarajan, Robert S. Genter, Michael W. LaRouche, Steven G. Mahon
2021	Nazzic S. Keene	Prabu Natarajan, Charles A. Mathis, Robert S. Genter, Michael W. LaRouche, Steven G. Mahon

(2) In accordance with Item 402(v) requirements, the fair value of unvested and outstanding equity awards included in the CAP columns were

remeasured as of the end of each fiscal year, and as of each vesting date, during the fiscal years displayed in the table above. Fair values

as of each measurement date were determined using valuation assumptions and methodologies that are consistent with those used to

estimate fair value in accordance with ASC Topic 718. The fair value of options was determined by using a lattice model, the fair value of the

TSR-modifier and relative TSR-based PSUs was determined by using a Monte Carlo simulated pricing model, non-market based PSUs

reflect the probable outcome of the performance vesting conditions as of each measurement date, and RSUs fair value equals the stock

price on the appropriate measurement date.

(3) For the portion of CAP that is based on the Company's fiscal year-end stock prices, the following prices were used for 2025: $ 108.28 , for

2024: $ 129.01 , for 2023: $ 104.08 , for 2022: $ 81.32 , and for 2021: $ 96.03 .

(4) The dollar amounts reported represent the amount of CAP as computed in accordance with Item 402(v) of SEC Regulation S-K. A

reconciliation of Total Compensation from the SCT to CAP to the PEO and our Non-PEO NEOs (as an average) is shown below:

Adjustments	2025	First PEO (Keene) — 2024	2023	2022	2021
Total Compensation from SCT	—	$ 12,895,917	$ 8,664,380	$ 8,343,156	$ 6,936,702
Adjustments for stock and option awards:
(Subtraction): SCT Amounts	—	( 7,254,762 )	( 5,840,076 )	( 5,333,701 )	( 4,200,061 )
Addition: Fair value at year-end of awards granted during the covered fiscal year that are outstanding and unvested at year-end	—	6,128,313	7,124,332	5,194,332	5,837,530
Addition (Subtraction): Year-over-year change in fair value of awards granted in any prior fiscal year that are outstanding and unvested at year end	—	1,734,628	1,852,379	( 1,238,005 )	593,158
Addition: Vesting date fair value of awards granted and vesting during such year	—	2,918,464	—	—	—
Addition (Subtraction): Change as of the vesting date (from the end of the prior fiscal year) in fair value of awards granted in any prior fiscal year for which vesting conditions were satisfied during such year	—	2,283,842	1,286,527	( 762,622 )	( 226,955 )
Addition: Dividends or other earnings paid on stock or option awards in the covered year prior to vesting if not otherwise included in the total compensation for the covered year	—	245,564	203,232	180,932	120,168
Compensation Actually Paid (as calculated)	$ —	$ 18,951,966	$ 13,290,774	$ 6,384,092	$ 9,060,542

68 | Science Applications International Corporation | 2025 Proxy Statement

EXECUTIVE COMPENSATION

Adjustments	2025	Second PEO (Townes-Whitley) — 2024	2023	2022	2021
Total Compensation from SCT	$ 10,241,743	$ 10,990,318	$ —	$ —	$ —
Adjustments for stock and option awards:
(Subtraction): SCT Amounts	( 6,384,074 )	( 7,175,963 )	—	—	—
Addition: Fair value at year-end of awards granted during the covered fiscal year that are outstanding and unvested at year-end	5,966,499	9,606,473	—	—	—
Addition (Subtraction): Year-over-year change in fair value of awards granted in any prior fiscal year that are outstanding and unvested at year end	( 1,468,134 )	—	—	—	—
Addition: Vesting date fair value of awards granted and vesting during such year	—	—	—	—	—
Addition (Subtraction): Change as of the vesting date (from the end of the prior fiscal year) in fair value of awards granted in any prior fiscal year for which vesting conditions were satisfied during such year	( 98,246 )	—	—	—	—
Addition: Dividends or other earnings paid on stock or option awards in the covered year prior to vesting if not otherwise included in the total compensation for the covered year	174,574	52,595	—	—	—
Compensation Actually Paid (as calculated)	$ 8,432,362	$ 13,473,423	$ —	$ —	$ —

Adjustments	2025	Average of Other NEOs — 2024	2023	2022	2021
Total Compensation from SCT	$ 3,043,064	$ 4,541,334	$ 4,681,658	$ 2,563,133	$ 1,945,432
Adjustments for stock and option awards:
(Subtraction): SCT Amounts	( 1,548,968 )	( 1,575,993 )	( 3,040,104 )	( 1,160,628 )	( 990,070 )
Addition: Fair value at year-end of awards granted during the covered fiscal year that are outstanding and unvested at year-end	1,457,430	1,654,263	3,223,412	1,130,294	1,295,882
Addition (Subtraction): Year-over-year change in fair value of awards granted in any prior fiscal year that are outstanding and unvested at year end	( 200,391 )	620,349	379,538	( 211,064 )	105,297
Addition: Vesting date fair value of awards granted and vesting during such year	—	311,011	—	—	—
Addition (Subtraction): Change as of the vesting date (from the end of the prior fiscal year) in fair value of awards granted in any prior fiscal year for which vesting conditions were satisfied during such year	( 168,756 )	752,594	237,325	( 117,602 )	( 56,875 )
Addition: Dividends or other earnings paid on stock or option awards in the covered year prior to vesting if not otherwise included in the total compensation for the covered year	46,063	83,864	41,672	35,814	22,799
Compensation Actually Paid (as calculated)	$ 2,628,442	$ 6,387,422	$ 5,523,501	$ 2,239,947	$ 2,322,465

(5) Peer Group TSR reflects the Company’s selected peer group, the Dow Jones US Computer Services Index, as reflected in our Annual

Report on the Form 10-K pursuant to Item 201(e) of Regulation S-K for the fiscal year ended January 31, 2025. The Company and peer

group TSR for each year reflects what the cumulative value of $100 would be, including the reinvestment of dividends, if such amount were

invested on January 31, 2020 (the last day of fiscal 2020) through and including the end of the fiscal year for each year reported in the table.

(6) Net income is as listed on our Annual Report on Form 10-K in accordance with U.S. GAAP.

(7) Revenue is the financial measure from the tabular list of fiscal 2025 Most Important Measures shown below which, in the Company’s

assessment, represents the most important performance measure used to link CAP to our PEO and Non-PEO NEOs to the Company’s

performance for fiscal 2025. Revenue is as listed on our Annual Report on the Form 10-K in accordance with U.S. GAAP.

saic.com | 69

EXECUTIVE COMPENSATION

Tabular List of Important Financial Performance Measures

The following table lists the most important financial performance measures we used to link CAP to our executives to Company

performance for the most recently completed fiscal year. These measures are utilized in our short-term and long-term incentive

plans, and are aligned with our pay for performance philosophy. For further information regarding these performance metrics in

our incentive programs, please see the "Compensation Discussion and Analysis" beginning on page 40.

Most Important Measures (Unranked)
Revenue
Adjusted EBITDA (1)
Adjusted Operating Cash Flow (1)

(1) Adjusted EBITDA and adjusted operating cash flow are non-GAAP measures. See the Appendix to this Proxy Statement for a reconciliation

as to how each adjusted non-GAAP performance measure for the performance stock units is calculated as compared to the most closely

comparable GAAP measure.

70 | Science Applications International Corporation | 2025 Proxy Statement

EXECUTIVE COMPENSATION

Relationship between Pay and Performance

The following charts present a graphical comparison of CAP and performance figures that are included in the pay versus

performance tabular disclosure above. In addition, the first graph below presents the relationship between the Company’s TSR

and that of the selected peer group, the Dow Jones US Computer Services Index. As noted above, CAP for purposes of the

tabular disclosures and the following charts were calculated in accordance with SEC rules and do not fully represent the actual

final amount of compensation earned by or actually paid to our PEO and NEOs during the applicable fiscal years.

Compensation Actually Paid and Company/Peer Group Total Shareholder Return

Compensation Actually Paid and Net Income

Compensation Actually Paid and Revenue

saic.com | 71

EXECUTIVE COMPENSATION

72 | Science Applications International Corporation | 2025 Proxy Statement

PROPOSAL 3 - RATIFICATION OF

APPOINTMENT OF INDEPENDENT

REGISTERED PUBLIC ACCOUNTING FIRM

The Board unanimously

recommends a vote FOR

t his Proposal.

The Audit Committee believes that the appointment of Ernst & Young LLP ("EY") is in the best interests of the company and its

stockholders, and proposes and recommends that the stockholders ratify the Audit Committee’s appointment of EY as our

independent registered public accounting firm to audit our consolidated financial statements for the fiscal year ending January

30, 2026. Representatives of EY will be present at the virtual annual meeting to respond to appropriate questions and will have

the opportunity to make a statement if they desire to do so.

Stockholders are not required to ratify the appointment of EY as our independent registered public accounting firm. However, we

are submitting the appointment for ratification as a matter of good corporate practice. If stockholders fail to ratify the appointment,

the Audit Committee will consider whether or not to retain EY. Even if the appointment is ratified, the Audit Committee may direct

the appointment of a different independent registered public accounting firm at any time during the year if it determines that a

change in accounting firms would be in our stockholders’ best interests.

Vote Required

The affirmative vote of the holders of a majority of the voting power of common stock present or represented and entitled to vote

on Proposal 3 either in person or by proxy is required to approve the proposal. Abstentions have the effect of a vote against the

proposal, and broker “non-votes” have no effect on the outcome of the proposal. Shares of common stock represented by

properly executed, timely received and unrevoked proxies will be voted in accordance with the instructions indicated thereon. In

the absence of specific instructions, properly executed, timely received and unrevoked proxies will be voted “FOR” the proposal.

Recommendation of the Board

The Board unanimously recommends a vote FOR the ratification of the appointment of Ernst & Young LLP as our independent

registered public accounting firm for the fiscal year ending January 30, 2026.

73 | saic.com

74 | Science Applications International Corporation | 2025 Proxy Statement

AUDIT MATTERS

AUDIT MATTERS

Audit Committee Report

The Audit Committee of the Board is responsible for assisting the Board in fulfilling its oversight responsibilities over the

company’s accounting, auditing and financial reporting processes, internal controls, and for monitoring compliance with certain

regulatory and legal requirements. The responsibilities of the Audit Committee are described in a written charter that has been

reviewed and approved by the Board. The current Audit Committee charter is available on the company’s investor relations

website at investors.saic.com by clicking on the link entitled “Corporate Governance.” A summary of the provisions of the Audit

Committee charter, including the responsibilities of the Audit Committee, is set forth in this Proxy Statement under "Corporate

Governance – Audit Committee," beginning on page 27.

Management is responsible for preparing the company’s financial statements and for the financial reporting process, including

evaluating the effectiveness of the company’s disclosure controls and procedures and internal control over financial reporting.

EY, the company’s independent registered public accounting firm for fiscal 2025, is responsible for performing an independent

audit of the company’s annual consolidated financial statements and expressing an opinion on the conformity of the financial

statements with accounting principles generally accepted in the United States of America, and on the effectiveness of the

company’s internal control over financial reporting.

Each current Audit Committee member (Carolyn B. Handlon, Yvette M. Kanouff, Timothy J. Mayopoulos, Milford W. McGuirt, and

James C. Reagan ) meets the independence and financial literacy requirements of the SEC and Nasdaq as well as qualifies as

an audit committee financial expert under SEC rules. For a further description of each Audit Committee member’s background

and expertise, please refer to the director qualification section of this Proxy Statement beginning on page 13.

In the course of fulfilling its responsibilities, the Audit Committee has:

• evaluated the qualifications, performance and compensation of the company’s independent auditor (EY);

• separately met with the internal auditor and EY to discuss any matters that the internal auditor, EY or the Audit Committee

believed should be discussed privately without members of management present;

• reviewed and discussed with EY the items required to be disclosed under the applicable requirements of the Public

Company Accounting Oversight Board (“PCAOB”) and the SEC;

• received written disclosures and the letter from EY regarding its independence required by applicable requirements of the

PCAOB, and discussed with EY its independence;

• reviewed and discussed with management and EY the company’s internal control over financial reporting; and

• reviewed and discussed with management and EY the audited consolidated financial statements for fiscal 2025.

Based on the reviews and discussions summarized in this report and subject to the limitations on our role and responsibilities

referred to above and contained in the Audit Committee charter, the Audit Committee recommended to the Board that the

company’s audited consolidated financial statements referred to above be included in the company’s Annual Report on Form

10-K for fiscal 2025 for filing with the SEC.

Milford W. McGuirt (Chair)

Carolyn B. Handlon

Yvette M. Kanouff

Timothy J. Mayopoulos

James C. Reagan

Independent Registered Public Accounting Firm

The Audit Committee of the Board has appointed Ernst & Young LLP as the independent registered public accounting firm to

audit our financial statements for the company's fiscal year ending January 30, 2026. Stockholders are being asked to ratify the

appointment of Ernst & Young LLP at the annual meeting, as described above.

saic.com | 75

AUDIT MATTERS

Audit and Non-Audit Fees

Aggregate fees billed to the company for fiscal 2025 and fiscal 2024 by our independent registered public accounting firm, EY,

were as follows:

	January 31, 2025	February 2, 2024
Audit Fees (1)	$ 5,005,000	$ 4,663,500
Audit-Related Fees (2)	$ 7,200	$ 7,200
Tax Fees (3)	$ 241,002	$ 267,800
All Other Fees	$ —	$ —
Total Fees	$ 5,253,202	$ 4,938,500

(1) Audit Fees consist of professional services rendered for the audit of the annual consolidated financial statements, including the audit of

internal controls pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, and the review of quarterly consolidated financial statements.

Audit fees also include services that are normally provided by the accountant in connection with the audit, such as consents and certain

other company filings and submissions with the SEC.

(2) Audit-Related Fees reflect fees for services that are reasonably related to the performance of the audit or review of the company’s financial

statements. For fiscal 2025 and 2024, this included fees for online accounting research access.

(3) Tax Fees include a variety of permissible tax services related to preparation and/or review of statutory tax filings within U.S., foreign, and

state jurisdictions, general tax advisory services (including research and discussions related to tax compliance matters) and assistance with

credits and incentives opportunities in various jurisdictions.

The Audit Committee has considered whether the above services provided by EY are compatible to maintaining the

independence of EY. The Audit Committee has the responsibility to pre-approve all audit and non-audit services to be performed

by the independent registered public accounting firm in advance. Further, the Chair of the Audit Committee has the authority to

pre-approve audit and non-audit services as necessary between regular meetings of the Audit Committee, provided that any of

those services that were pre-approved in that manner will be disclosed to the full Audit Committee at its next scheduled meeting.

All of the Audit Fees, Audit-Related Fees, non-audit Tax Fees, and All Other Fees set forth above were pre-approved by one of

these means.

76 | Science Applications International Corporation | 2025 Proxy Statement

saic.com | 77

OTHER INFORMATION

Stock Ownership of Certain Beneficial Owners

The following table provides information regarding the beneficial ownership of each person known by us to beneficially own more

than five percent of SAIC common stock as of April 7, 2025.

Name and address of beneficial owner	Amount and nature of beneficial ownership	Percent of class
The Vanguard Group (1)	4,759,939	10.1 %
100 Vanguard Blvd. Malvern, PA 19355
BlackRock, Inc. (2)	4,381,959	9.3 %
55 East 52nd Street New York, NY 10055

(1) Information shown is based solely on stock ownership information reported by the filer on a Form 13F filed with the SEC on February 11,

2025 with respect to holdings as of December 31, 2024. Based on a Schedule 13G/A filed with the SEC on February 13, 2024, The

Vanguard Group, an investment adviser filing on behalf of itself and certain of its subsidiaries, reported that it beneficially owned 5,147,005

shares as of December 29, 2023, including shared voting power over 20,506 shares, sole dispositive power over 5,076,440 shares and

shared dispositive power over 70,565 shares .

(2) Information shown is based solely on stock ownership information reported by the filer on a Form 13F filed with the SEC on February 7,

2025 with respect to holdings as of December 31, 2024. Based on a Schedule 13G/A filed with the SEC on January 24, 2024, BlackRock,

Inc., a holding company filing on behalf of itself and certain of its subsidiaries, reported that it beneficially owned 4,876,090 shares as of

December 31, 2023, including sole voting power over 4,654,650 shares and sole dispositive power over 4,876,090 shares.

78 | Science Applications International Corporation | 2025 Proxy Statement

OTHER INFORMATION

Stock Ownership of Directors and Officers

The following table sets forth, as of April 7, 2025, the beneficial ownership of our common stock by our directors, the NEOs, and

all of our directors and executive officers as a group. None of our directors or executive officers beneficially own more than one

percent of our common stock. As a group, our directors and executive officers beneficially own approximately 0. 44 % of our

common stock. Unless otherwise indicated, each individual has sole investment power and sole voting power with respect to the

shares beneficially owned by that individual, except for any investment or voting power that may be shared with a spouse. No

shares have been pledged.

Beneficial Owner	Common stock (1)	Stock units (2)	Options and RSUs (3)	Total shares beneficially owned
Non-Employee Directors
Garth N. Graham	5,493	—	1,451	6,944
Carolyn B. Handlon	2,581	—	1,451	4,032
Yvette M. Kanouff	9,718	—	1,451	11,169
Timothy J. Mayopoulos	6,476	—	1,451	7,927
Katharina G. McFarland	5,643	—	1,451	7,094
Milford W. McGuirt	5,390	—	1,451	6,841
Donna S. Morea	32,376	—	4,327	36,703
James C. Reagan	2,716	—	1,451	4,167
Steven R. Shane	35,389	—	4,327	39,716
John K. Tien, Jr.	215	—	704	919
Named Executive Officers
Toni Townes-Whitley	13,012	—	—	13,012
Prabu Natarajan	54,054	—	—	54,054
Srinivas Attili	300	—	—	300
Hilary L. Hageman	8,227	—	—	8,227
David C. Ray	8,319	—	—	8,319
All directors and executive officers as a group (15 persons)	189,909	—	19,515	209,424

(1) Information in this column includes (a) the approximate number of shares allocated to all directors and officers as a group, 183,575 shares,

and (b) shares held by certain trusts established by the individuals as follows: Mr. Shane, 1,334 shares; and Mr. Natarajan, 5,000 shares.

(2) Represents vested stock units attributable to the individual or the group in the Management Stock Compensation Plan or Key Executive

Stock Deferral Plan. Shares held in these plans are voted by the trustee in the same proportion as all other stockholders collectively vote

their shares of common stock.

(3) Shares subject to options exercisable or RSUs subject to vesting, both within 60 days following April 7, 2025.

Delinquent Section 16(a) Reports

Section 16(a) of the Exchange Act and the rules of the SEC require our directors and executive officers as well as persons who

beneficially own more than ten percent of our common stock to file reports of their ownership and changes in ownership of

common stock with the SEC. For our directors and executive officers, our personnel generally prepare and file these reports on

the basis of information obtained from each director and officer and pursuant to a power of attorney. Due to an administrative

oversight a Form 4 reporting one transaction for Mr. DiFronzo was filed late during fiscal 2025. Based solely on the information

provided to us, we believe that all other reports for our directors, executive officers and greater than ten percent stockholders

complied with all filing requirements under Section 16(a) of the Exchange Act during fiscal 2025.

saic.com | 79

OTHER INFORMATION

Stockholder Proposals and Director Nominations for the 2026

Annual Meeting

Stockholders who, in accordance with Rule 14a-8 of the Exchange Act, wish to present proposals for inclusion in the proxy

materials to be distributed in connection with next year’s annual meeting must submit their proposals so they are received by our

Corporate Secretary no later than the close of business (5:00 p.m. ET) on December 25, 2024. As the rules of the SEC make

clear, simply submitting a proposal does not guarantee that it will be included.

In order to be properly brought before the annual meeting of stockholders to be held in 2026 (the "2026 Annual Meeting"), a

stockholder who desires to provide notice of nomination of one or more director candidates to be included in the company’s

Proxy Statement and ballot pursuant to Section 3.17 of our bylaws (a “proxy access nomination”) must be received by our

Corporate Secretary no earlier than November 24, 2025 and no later than the close of business on December 24, 2025 (not later

than the close of business on the 120th day nor earlier than the close of business on the 150th day prior to the first anniversary

of the date the definitive Proxy Statement was first released to stockholders in connection with the preceding year’s annual

meeting of stockholders). If the date of the 2026 Annual Meeting is more than 30 days before or more than 70 days after that

anniversary date, notice of the proxy access nomination by the stockholder to be timely must be received not earlier than the

close of business on the 120th day and not later than the close of business on the later of the 90th day prior to the 2026 Annual

Meeting or the close of business on the 10th day following the day on which the notice of proxy access nomination is mailed or

public announcement of the date of the 2026 Annual Meeting is first made by the company, whichever first occurs.

In addition, in order for a stockholder to propose any matter for consideration at the 2026 Annual Meeting other than by inclusion

in the Proxy Statement, the stockholder must give timely notice to our Corporate Secretary of such stockholder's intention to

bring such business before the meeting. To be timely, notice must be delivered to the Corporate Secretary not later than the

close of business on the 90th day, nor earlier than the close of business on the 120th day, prior to the first anniversary of the

preceding year’s annual meeting. Therefore, in connection with the 2026 Annual Meeting, notice must be delivered to the

Corporate Secretary between February 4, 2026 and March 6, 2026. In the event, however, that the date of the 2026 Annual

Meeting is more than 30 days before or more than 70 days after such anniversary date, notice by the stockholder must be

delivered not earlier than the close of business on the 120th day prior to such annual meeting and not later than the close of

business on the 90th day prior to such annual meeting or the 10th day following the day on which public announcement of the

date of such meeting is first made by us, whichever occurs later.

Any stockholder’s notice must include additional information about the stockholder and the underlying beneficial owner, if any,

required under our bylaws, as amended from time to time, and SEC rules and regulations, including the information that would

be required to be disclosed in a Proxy Statement soliciting proxies for the election of any proposed nomination of one or more

director candidates. A stockholder’s notice must be updated, if necessary, so that the information submitted is true and correct as

of the record date for determining stockholders entitled to receive notice of the meeting.

In addition to the requirements set forth above, stockholders who intend to solicit proxies in support of director nominees other

than the company’s nominees must comply with the additional requirements of Rule 14a-19(b) under the Exchange Act.

Annual Report on Form 10-K

We will provide without charge to any stockholder, upon written or oral request, a copy of our Annual Report on Form 10-K for

fiscal 2025 without exhibits. Requests should be directed to SAIC, 12010 Sunset Hills Road, Reston, Virginia 20190, Attention:

Corporate Secretary, or by calling (703) 676-4008.

By Order of the Board of Directors

Hilary L. Hageman

Corporate Secretary

April 23, 2025

80 | Science Applications International Corporation | 2025 Proxy Statement

saic.com | 81

APPENDICES

APPENDICES

Appendix A: Non-GAAP Financial Measures

This appendix describes the non-GAAP financial measures included in the Proxy Statement. While we believe that these non-

GAAP financial measures may be useful in evaluating our financial information, they should be considered as supplemental in

nature and not as a substitute for financial information prepared in accordance with GAAP. Other companies may define similar

measures differently.

	Year Ended — January 31, 2025	February 2, 2024	February 3, 2023
	(in millions)
Revenues	$7,479	$7,444	$7,704
Net income	362	477	303
Interest expense, net and loss on sale of receivables	140	129	126
Provision for income taxes	66	143	72
Depreciation and amortization	140	142	157
EBITDA (1)	$708	$891	$658
EBITDA as a percentage of revenues	9.5%	12.0%	8.5%
Acquisition and integration costs	(2)	1	13
Restructuring and impairment costs	8	23	24
Depreciation included in acquisition and integration costs and restructuring and impairment costs	(1)	(1)	(3)
Recovery of acquisition and integration costs and restructuring and impairment costs (2)	(3)	(6)	(12)
Gain on divestitures, net of transaction costs	—	(240)	—
Adjusted EBITDA (1)	$710	$668	$680
Adjusted EBITDA as a percentage of revenues	9.5%	9.0%	8.8%

(1) EBITDA is a performance measure that is calculated by taking net income and excluding interest and loss on sale of receivables, provision

for income taxes, and depreciation and amortization. Adjusted EBITDA is a performance measure that excludes acquisition and integration

costs, impairments, restructuring costs, and any other material non-recurring costs that we do not consider to be indicative of our ongoing

operating performance. Integration costs are costs to integrate acquired companies and include the costs of strategic consulting services,

facility consolidation and employee related costs such as retention and severance costs. The acquisition and integration costs relate to the

company’s acquisitions. We believe that these performance measures provide management and investors with useful information in

assessing trends in our ongoing operating performance and may provide greater visibility in understanding the long-term financial

performance of the company.

(2) Adjustment to reflect the portion of acquisition and integration costs and restructuring and impairment costs recovered through the

company's indirect rates in accordance with Cost Accounting Standards.

82 | Science Applications International Corporation | 2025 Proxy Statement

APPENDICES

In addition to the above non-GAAP financial measures, the table below describes adjusted performance measures related to the

Performance Stock Units and Short-Term Incentive ("STI") Awards included in the Proxy Statement.

	Year Ended — January 31, 2025	February 2, 2024	February 3, 2023
	(in millions)
Performance Stock Units Adjusted Performance Measures
Net income	$362	$477	$303
Interest expense, net and loss on sale of receivables	140	129	126
Provision for income taxes	66	143	72
Depreciation and amortization	140	142	157
EBITDA (1)	$708	$891	$658
EBITDA as a percentage of revenues	9.5%	12.0%	8.5%
Acquisition and integration costs	(2)	1	11
Restructuring impacts	4	16	11
Divestiture impacts	—	(240)	—
Legal settlements	—	2	—
Performance stock units adjusted EBITDA	$710	$670	$680
Performance stock units adjusted EBITDA as a percentage of revenues	9.5%	9.0%	8.8%
Cash flows provided by operating activities	$494	$396	$532
Excess tax benefits on stock based compensation	(5)	(6)	(4)
Cash paid for acquisition and integration costs	—	5	28
Restructuring impacts	7	(1)	(5)
Platform integration program working capital changes	72	28	9
Section 174 and related changes	54	75	68
Divestiture impacts	8	72	—
Impact from sale of receivables under Master Accounts Receivable Purchase Agreement	41	45	(50)
Legal settlements	2	—	—
Performance stock units adjusted operating cash flow	$673	$614	$578
Short-Term Incentive Adjusted Performance Measures
Revenue and STI adjusted revenue	$7,479	$7,444	$7,704
Net income	$362	$477	$303
Interest expense, net and loss on sale of receivables	140	129	126
Provision for income taxes	66	143	72
Depreciation and amortization	140	142	157
EBITDA (1)	$708	$891	$658
EBITDA as a percentage of revenues	9.5%	12.0%	8.5%
Acquisition and integration costs	(2)	1	11
Restructuring impacts	4	16	11
Divestiture impacts	—	(240)	—
Gain on sale of equity method investment	(5)	—	—
Executive transition	—	13	—
STI adjusted EBITDA	$705	$681	$680
Cash flows provided by operating activities	$494	$396	$532
Excess tax benefits on stock based compensation	(5)	(6)	(4)
Impact from sale of receivables under Master Accounts Receivable Purchase Agreement	41	45	(50)
Section 174 and related changes	—	—	68
Divestiture impacts	8	72	—
Executive transition	—	1	—
STI adjusted operating cash flow	$538	$508	$546

saic.com | 83

APPENDICES

(1) EBITDA is a non-GAAP performance measure that is calculated by taking net income and excluding interest and loss on sale of receivables,

provision for income taxes, and depreciation and amortization. We believe that this performance measure provides management and

investors with useful information in assessing trends in our ongoing operating performance and may provide greater visibility in

understanding the long-term financial performance of the company.